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10:00 a.m.
1005-29	 Fetal	Cardiac	Ventricular	Volumes	Derived	From	3D/4D	
Echo:	Definitive	Data	From	Two	Different	Types	of	3D	
Ultrasound	Systems
Boris Tutschek, Ling Hui, Patricia A. Robertson, Michael Schaal, Mary S. Minette, David 
J. Sahn, Oregon Health & Science University, Portland, OR
Background: Because of their unusual shapes in the fetus, 2D echo does not yield 
adequate data for the right and left ventricular (RV, LV) chamber volumes. Previously 
published 3D/4D data has been from a 5-7 MHz mechanical sweep system and 
spaciotemporal reconstruction (STIC). Recently, matrix based 3D/4D imaging has 
achieved adequate resolution for measurement of fetal ventricular volumes.
Methods: We studied 30 patients (21-34y) with STIC and 33 fetuses (16-36 wk gestation) 
using a 3-1-MHz 2D matrix array transducer (x3-1/iE33, Philips) or a 7 MHz transducer. Full 
4D volumes were acquired with an internal HR trigger in the system. End diastolic and end 
systolic RV and LV volumes and ejection fraction were determined for both ventricles.
Results: Measurements of one or both fetal cardiac ventricles could be successfully 
obtained in 25 of the 33 fetuses. A total of 115 “full cardiac volumes” (between one and 11 
per fetus) were analyzed. Between 20 and 36 weeks´ gestation fetal ventricular volumes 
in ED and ES increase from 0.4ml to 4ml and 0.2ml to 1.7ml for the RV and from 0.4ml to 
3.3ml and 0.3ml to 1.7ml for the LV.
Conclusion: Because similar results for chamber growth and function have been 
observed in our study from the two most widely used 4D methods for fetal cardiac 
imaging, it is likely that the measurements are definitive and universal.
10:00 a.m.
1005-30	 PRISM-III	Predicts	Death	Among	Medical	Admissions	to	
a	Pediatric	Cardiac	Intensive	Care	Unit
Lily A. Maltz, Peter C. Laussen, Gareth J. Parry, Kimberlee Gauvreau, Kathy J. Jenkins, 
Ravi R. Thiagarajan, Children’s Hospital Boston, Boston, MA
Background: The validity of Pediatric Risk of Mortality Score-III (PRISM-III) to predict 
death for children with cardiac disease has been questioned. We examined the 
performance of PRISM-III scores for predicting mortality among patients admitted to a 
pediatric Cardiac Intensive Care unit (CICU) for medical indications.
Methods:	Demographic and physiological data during the first 24 hours of admission 
were collected, and the PRISM-III was calculated for all patients admitted to our CICU 
for medical indications during 2003. Factors associated with mortality during the CICU 
admission were evaluated using Fisher’s exact test, and performance of PRISM-III was 
assessed using ROC analysis.
Results: Among 1,176 total admissions, there were 268 (23%) admissions in 230 
patients for cardiac medical indications. Cases were 57% male, with median age: 2.7 yr 
(range; 0 - 42.2), CICU length of stay: 1 day (0 - 57) and PRISM-III: 3 (0 - 35). Common 
indications for CICU admission were recovery following cardiac catheterization (31%), 
arrhythmia (16%), and cardiac failure management (12%). Common cardiac diagnoses 
were two ventricle lesions (50%), single ventricle lesions (21%), and cardiomyopathy 
(12%). ICU death occurred in 7%, compared to 2% for cardiac surgical admissions to 
the CICU during the same time period. Mortality rate was highest for adults ≥ 18 years 
(18%) and neonates ≤ 30 days (12%) compared to other age groups (2%, p<0.001). 
Patients admitted with cardiomyopathy had a higher mortality rate compared to other 
diagnosis groups (19% vs. 5%, p=0.007). Mortality rate also differed by indication for 
CICU admission, and was highest for cardiogenic shock (56%) and lowest for patients 
admitted with pericardial effusion and arrhythmias (0%, p<0.001). Median PRISM-III was 
higher for non-survivors compared with survivors (19 vs. 3, p<0.001) and had an area 
under the ROC curve of 0.844 for predicting mortality. 
Conclusions:	PRISM III scores were highly predictive of death for patients admitted 
to a pediatric CICU for medical indications. Death risk was substantially higher among 
medical admissions compared to children undergoing cardiac surgery.
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10:00 a.m.
1005-27	 Treatment	of	Severe	Metabolic	Syndrome	With	
Gemfibrozil	in	a	Pediatric	Population
Courtney M. Smalley, Stanley J. Goldberg, University of Arizona, Tucson, AZ
Background:	Gemfibrozil has been proven to safely reduce cardiac risk in adults but has 
not been evaluated in a pediatric population. The purpose of this study was to investigate 
whether gemfibrozil will lower triglycerides and raise high density lipoprotein (HDL) with 
minimal adverse effects in a pediatric population with severe metabolic syndrome.
Methods: We conducted a retrospective study of 55 pediatric patients who started 1200 
mg gemfibrozil/day for clinical indications. Eligibility for inclusion required patients have 
metabolic syndrome, to be <21 years of age beginning treatment, and have pre and on-
treatment fasting lipid profiles. Data collected included age at start of treatment, blood 
pressure, body mass index (BMI), waist circumference, and % body fat. Total cholesterol, 
HDL, low density lipoprotein (LDL), triglycerides, alanine transferase (ALT), and aspartate 
transferase (AST) were recorded. Duration of treatment was elapsed time between 
starting gemfibrozil and the last clinic visit.
Results: 40/55 patients had pre and on-treatment data. The average age at start of 
treatment for the 40 patients meeting inclusion criteria was 13 years and the mean 
duration on medication was 249 days. 30/40 of included patients had evidence of non-
alcoholic steatohepatitis by elevated ALT/ AST or biopsy or both. On treatment mean 
triglyceride levels decreased by 54%: 388 mg/dl (SE =33.3) to 179 mg/dl (SE= 18) 
(p<0.0001). Mean HDL increased significantly by 17% (p<0.001) from 36 mg/dl to 42 mg/
dl. Additionally, mean liver enzymes, ALT and AST, decreased from 57 to 35 IU/L (38%) 
and 39 to 28 IU/L (28%), respectively (p=0.001, p=0.006). BMI, waist circumference, and 
% body fat did not change significantly indicating that the reduction in triglycerides and 
the increase in HDL can be attributed to gemfibrozil. 3/55 patients reported muscle pain, 
2 of whom were considered secondary to gemfibrozil. 49/55 had no adverse effects and 
4 were lost to follow-up without adverse effect information.
Conclusions:	 This study shows that gemfibrozil significantly raises HDL and lowers 
triglycerides, ALT, and AST with reasonable safety in a pediatric population with severe 
metabolic syndrome.
10:00 a.m.
1005-28	 Assessment	of	Myocardial	Perfusion	and	Coronary	
Flow	Reserve	in	Children,	Using	3-Tesla	Cardiac	
Magnetic	Resonance
Ronald Wells, Michael Jerosch-Herold, David Sahn, Katharine Hopkins, William 
Woodward, Erwin Schwartz, Veronica Swanson, Daniel J. Woodward, Angela 
Zimmerman, Michael Silberbach, Oregon Health and Science University, Portland, OR
Introduction: The feasibility of measuring myocardial blood flow (MBF) and coronary flow 
reserve (CFR) in pediatrics by cardiac magnetic resonance (cMR) has not been reported.
Methods: We conducted 11 adenosine-infusion cMR (AI-cMR) studies in 10 children 
(2.9m-17.3y) with TGA post arterial switch (2), anomalous coronary artery origin (3; 4 
studies), Kawasaki Disease (2), PA-IVS-RVDCC (1), TOF (1), and double outlet right 
ventricle (1). Single-shot gradient echo perfusion images were acquired with gadolinium 
(0.03mmol/kg) before and during myocardial hyperemia induced by adenosine infusion 
(140mcg/kg/min). An anesthesiologist sedated any child <12y. Images were segmented 
to derive curves of contrast enhancement for 6-8 myocardial sectors per slice and MBF 
was estimated by model-independent deconvolution, using arterial input measured in the 
LV. CFR is hyperemic MBF divided by baseline MBF. There were no complications.
Results: Heart rate increased 13.8 bpm (-2 to +35). Blood pressure fell 9.3 mmHg (-25 
to +11). In 2 patients MBF and CFR were probably normal (CFR 2.67 ± 0.45). 8 patients 
were probably abnormal (CFR 2.36 ± 0.68). 5 had regional perfusion abnormalities; 2 at 
baseline, 3 had decreased CFR.
(Figure: 8yo with region of decreased perfusion)
The patients with KD and PA-IVS-RVDCC had impaired global CFR.
Conclusion: AI-cMR is safe and will have significant clinical utility when MBF and CFR 
normal values are established for infants and children.
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1005-31	 Utility	of	Transthoracic	Three-Dimensional	Color	
Doppler	Echocardiography	for	Diagnosis	of	Congenital	
Aortic	Arch	Anomalies
Fong-Lin Chen, Shuping Ge, Chung Shan Medical University Hospital, Taichung City, 
Taiwan,ROC, Baylor College of Medicine, Texas Children’s Hospital and Texas Heart 
Institute, Houston, TX
Background: Accurate anatomic diagnosis and assessment of congenital aortic arch 
anomalies (AAAs) is imperative for clinical decision making and surgical intervention. 
Oftentimes, 2-dimensional echo (2DE)/Doppler can not make unequivocal diagnosis 
and assessment of AAAs. The new transthoracic 3-dimensional color Doppler 
echocardiography (3DCDE) may provide a useful and robust tool for assessing such 
complex anatomy in 3-dimensions. Therefore, this study sought to evaluate the utility of 
3DCDE for accurate diagnosis of AAAs.
Methods: A total of 27 patients (mean 4.4 ± 3.3 years) with AAAs underwent 3DCDE 
studies. Transthoracic rotational acquisition and reconstruction of sequential 2DE or real-
time 3DE was used to obtain a 3DCDE data set encompassing the entire aortic arch and 
branching vessels as well as pulmonary artery and its branches for volume-rendered 
3DCDE images. Volume-rendered 3DCDE images were obtained and analyzed. 
Diagnosis based on 3DCDE was made independently and compared with corroborative 
studies, including magnetic resonance imaging (MRI), computed tomography (CT), 
angiography or surgery in all patients.
Results: Transthoracic 3DCDE study was successfully performed in all patients. The AAAs 
included double aortic arch (N = 10); right aortic arch with aberrant left subclavian artery 
(SCA), Kommerell’s diverticulum and left ligamentum arteriosum (LA) (N = 10); left aortic 
arch with aberrant right SCA and right LA (N = 6) and persistant fifth aortic arch aberrant 
right SCA and right LA (N = 1). The AAAs were correctly diagnosed by 3DCDE in all patients 
when compared with results of MRI/CT, angiography and the findings at surgery, with a 
concordance rate of 100%. Misinterpretation was made by 2DE in one patient with double 
aortic arch. We also found that these 3DCDE images are more easily understood by the 
health care professionals, trainees, and patient families than the 2DE images.
Conclusion: This study suggests that 3DCDE can be used for accurate diagnosis of 
AAAs and may provide an effective alternative to MRI, CT or angiography for this group of 
patients.
10:00 a.m.
1005-32	 Congenital	Vascular	Rings	And	Slings	Are	A	
Significantly	Under-diagnosed	Cause	Of	Childhood	
Diseases:	Screening	Of	186,213	School-aged	Children	
By	Echocardiography
Fong-Lin Chen, Shiang-Suo Huang, Yi-Ching Li, Jung-Min Yu, Yeu-Sheng Tyan, Si-Wa 
Chen, Kuo-Shuen Chen, Ming-Cheng Lin, Long-Yau Lin, Ming-Chih Chou, Shuping Ge, 
Chung Shan Medical University Hospital, Taichung City, Taiwan,ROC, Baylor College of 
Medicine, Texas Children’s Hospital and Texas Heart Institute, Houston, TX
Background: The epidemiology of congenital cardiovascular diseases (CCVD), especially 
congenital vascular ring and sling abnormality (CVRSA), is inadequate in school-aged children.
Methods: From 2001 to 2004, 186,213 newly registered primary and junior high school 
children in Taichung County, Taiwan, were screened by medical history, physical examination, 
ECG and portable 2D echocardiography (2DE). If any significant CCVD, especially CVRSA, 
was suspected or not definitive, the patient was refereed to a tertiary care center for a 
complete evaluation, including a complete standard 2DE, CT, MRI or angiography.
Results: Of all the 186,213, a total of 2319 cases with CCVD were diagnosed with a 
prevalence of 12/1000. There was no new case of complex congenital heart diseases 
(CHD), except for asymptomatic L-TGA (n = 4). There were significant numbers of newly 
diagnosed isolated minor CHDs, including PFO (618), VSD (37), PDA (213), ASD (180), 
PS (54), AS (6), and others (17). Surprisingly, CVRSA was the most prevalent (6.0/1000) 
with most new cases (1113/1115) as a group in this cohort. The CVRSA included left aortic 
arch (LAA) with aberrant right subclavian artery (ASCA)(n = 992), pulmonary artery sling 
(PAS)(n = 11), or complete vascular ring (CVR)(n = 96); the last group consisted of right 
aortic arch with left ligamentum (n = 83), double aortic arch (n = 8) and circumflex arch (n 
= 3). Patients with LAA/ASCA and PAS have less common and less severe clinical signs 
and symptoms than CVR, including recurrent respiratory infections, asthma, dysphagia, 
FTT, exercise intolerance, seizure or mental retardation, etc. A total of 66(69%) patients 
with CVR underwent surgical correction with no mortality or significant complications.
Conclusions: CCVDs, when CVRSAs are included, have a higher prevalence in school-
aged children than indicated in the literature. CVRSAs are mostly undiagnosed and 
can cause significant morbidities. Echocardiography appears to be a sensitive tool for 
screening of CVRSAs. Awareness and cost- effective screening strategies are necessary 
for timely diagnosis and treatment of CVRSAs.
10:00 a.m.
1005-33	 Accuracy	of	Cuff	and	Echo	Doppler	Blood	Pressure	
Gradients	to	Detect	Recurrent	Aortic	Arch	Obstruction	
in	Infants	after	the	Norwood	Stage	I	Palliation
Priya Sekar, William Border, Thomas R. Kimball, Russel Hirsch, Peter B. Manning, Robert 
H. Beekman, III, Cincinnati Children’s Hospital and Medical Center, Cincinnati, OH
Background: Aortic arch obstruction is an important complication after the Norwood 
operation. Clinicians have relied on upper-lower limb cuff blood pressure (BP) gradients 
and echo Doppler gradients as noninvasive screening tests for early detection. However 
their accuracy has not been systematically tested. Thus, we sought to investigate the 
ability of cuff BP and echo Doppler gradients to predict significant arch obstruction in 
single ventricle patients after the Norwood operation.
Methods:	Consecutive patients who underwent a Norwood operation at our institution were 
identified. Cuff and echo Doppler BP gradients (corrected for proximal velocity) obtained 
immediately prior to pre-Glenn cath were compared to peak-to-peak systolic neoaortic arch 
gradients obtained at catheterization. Sensitivity, specificity, positive and negative predictive 
values (PPV and NPV) and likelihood ratios were calculated. ROC curves were generated 
using different cutpoints for cuff and echo gradients, evaluating their ability to predict a 
catheter gradient of >10 mmHg (considered a clinically significant gradient).
Results:	Cuff and Doppler BP gradients were obtained in 117 patients. Echo Doppler 
gradient cutpoints were more sensitive but less specific at detecting a cath gradient >10 
mmHg than cuff BP gradients (see table). 
Cath	
threshold
Cuff	gradient	cut	
points
Sensitivity	
(%)
Specificity	
(%) LR	+ LR-
PPV
(%)
NPV
(%)
Cath>10
(mmHg)
Cuff grad >0 59 62 1.6 0.7 62 59
Cuff grad >5 50 73 1.8 0.7 65 59
Cuff grad >10 50 77 2.2 0.7 69 61
Cuff grad >15 46 91 5.0 0.6 83 63
Cuff grad >20 36 96 8.0 0.7 89 60
Echo	gradient	cut	
points
PIPG >10 93 86 6.4 0.1 81 95
PIPG >20 85 95 17.9 0.2 92 91
PIPG >30 70 98 29.6 0.3 95 84
PIPG >40 44 100 100 1 100 74
Conclusion:	Echo Doppler outperforms cuff BP as a sensitive noninvasive screening tool 
for early detection of significant arch obstruction in infants after the Norwood operation.
10:00 a.m.
1005-48	 Persistent	Pulmonary	Hypertension	Of	The	Newborn	In	
patients	with	Transposition	of	The	Great	Arteries:	A	Ten	
year,	single-centre	experience	in	The	Nitrc	Oxide	era
Marcus T. Roofthooft, Klasina A. Bergman, Tjalling W. Waterbolk, Rolf M. Berger, 
University Medical Centre Groningen, Groningen, The Netherlands
Background: Persistent pulmonary hypertension of the Newborn (PPHN) in patients with 
transposition of the great arteries (TGA) is reported to be a high-risk and often therapy-
resistant condition, associated with high mortality. Data on its incidence and prognosis 
are scarce and originate mostly from the era before introduction of inhaled nitric oxide 
(iNO) therapy for PPHN.
Methods: Retrospective study of consecutive newborns with TGA, admitted to a tertiary 
neonatal intensive care unit over a 10 year period. In this period iNO-therapy was available.
Results: Fourteen out of 112 patients with TGA (12.5%) presented with associated 
PPHN. PPHN occurred more frequently in patients with TGA and intact ventricular 
septum (IVS) compared to those with TGA and ventricular septal defect (VSD)(13 out 
of 83 patients versus 1 out of 29 patients respectively; p=0.06 Fisher’s exact test). Of 
those newborns, 6 presented with severe PPHN (profound cyanosis and associated with 
echocardiographical continuous right-to-left shunting through a patent arterial duct (PDA) 
or a predominant right-to left shunt through the PDA associated with a pre- to postductal 
difference in transcutaneous oxygen saturation (δ-SO2) ≥ 15%), whereas 8 presented 
with mild-to-moderate PPHN (with echocardiographical bi-directional shunting through the 
PDA associated with δ-SO2 between 5 and 15% ). Despite currently available treatment 
modalities, including iNO, 4 out of 14 patients died before corrective surgical procedures 
were considered to be an option (TGA/PPHN preoperative mortality 28.6%). These 
included 3 out of 6 patients (50%) with severe PPHN and 1 out of 8 (12,5%) with mild-to-
moderate PPHN All PPHN patients, who did reach the Arterial Switch Operation, survived. 
Their postoperative course however, was significant longer (mechanical ventilation and 
ICU stay) in comparison to patients without PPHN (Mann-whitney U-test).
Conclusions: The combination of TGA with PPHN is a serious and often fatal condition. 
It may jeopardise the usually favourable outcome of newborns with TGA . Unfortunately, 
compared to available data in the literature, the introduction of iNO has not changed the 
mortality rate of this condition in our series.
10:00 a.m.
1005-49	 Is	Invasive	Hemodynamic	Assessment	Essential	Prior	
to	the	Fontan	Operation
Muhammad A. Khan, Welton M. Gersony, Rose Hardy, Alejandro J. Torres, Ralph S. 
Mosca, Ashwin Prakash, Columbia University College of Physicians and Surgeons, 
New York, NY
Background:	Suitability for the Fontan Operation is determined based upon evaluation 
of pulmonary arterial (PA) and venous anatomy, pulmonary artery pressure (PAP) and 
ventricular filling pressure (VFP) at cardiac catheterization. However, catheterization is 
invasive and carries significant risks. Although MRI or CT angiography are accurate in 
evaluating PA and venous anatomy, they are not routinely used for evaluation before the 
Fontan operation because PAP and VFP cannot be measured using these techniques. 
The aim of this study was to determine the proportion of patients who are excluded from 
the Fontan operation solely due to an elevated PAP/VFP, in the absence of acompanying 
angiographic abnormalities and/or clinical or echocardiographic risk factors.
Methods: Retrospective review of 153 children who underwent catheterization to 
determine suitability for the Fontan operation from 2000-2005 was performed to identify 
patients who were excluded from the Fontan operation. Data from catheterization, 
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echocardiography and clinical records were analyzed to determine the proportion of 
subjects who were excluded solely due to an elevated PAP/VFP.
Results:	After catheterization, 10/153 (6.5%) subjects were excluded from a Fontan 
operation. Only 3/10 (3.2%) subjects had solely elevated PAP and/or VFP, while 7/10 
had significant accompanying angiographic PA or venous abnormalities. All 3 patients 
with elevated PAP/VFP in absence of angiographic abnormalities had at least one 
clinical or echocardiographic risk factor including moderate or worse systemic ventricular 
dysfunction (n=2), moderate or worse atrioventricular valve regurgitation (n=1) or chronic 
lung disease (n=1). None of the excluded subjects had an elevated PAP/VFP in the 
absence of angiographic abnormalities and/or clinical/echocardiographic risk factors.
Conclusions:	Exclusion from the Fontan operation due to only an elevated PAP/VFP 
did not occur during a 5-year study period. Routine invasive measurement of PAP/
VFP may not be essential in patients without clinical/echocardiographic risk factors or 
abnormalities on non-invasive angiography. Such non-invasive stratagies should be 
evaluated prospectively.
10:00 a.m.
1005-51	 Stent	Implantation	for	the	Treatment	of	Adult	Aortic	
Coarctation:	Initial	and	Five-Year	Results
Basil D. Thanopoulos, Sofia Loukopoulou, Evangelia Basta, Nicholaos Eleftherakis, 
Ioannis Skoularigis, Fillipos Triposkiadis, “Aghia Sophia” Children’s Hospital, Athens, 
Greece, University Hospital of Thessaly, Larissa, Greece
Background: During the last decade there has been a significant number of reports 
of stent implantation (SI) for the treatment of coarctation of the aorta (CoA). Although 
these studies report quite satisfactory angiographic and hemodynamic results they have 
a very short to intermediate - term follow-up. This study reports initial and 5-year results 
following SI for adult CoA.
Methods: Thirty patients with CoA underwent SI (median age 35 years, range 23 - 58 
years); twenty patients were treated for isolated CoA and ten for recurrent CoA. Thirty-
one stents were implanted. Palmaz 4014 stents were placed in 22 patients, Palmaz 308 
in eight. Elective re-dilation of previously implanted stent was performed in 5 patients 
with quite severe CoA
Results: Immediately after SI the peak systolic gradient (mean (SD)) fell from 48 (18) 
mm Hg to 5.3 (3.8) mm Hg (p <0.05). The diameter of the CoA increased from 5.8 (3.2) 
mm to 17.2 (3.8) mm (p< 0.05). The main procedural complication was proximal stent 
migration (catheter treated) in one patient. There were no early or late deaths, or any 
evidence of early or late aneurysm formation or any other complication related to SI 
throughout the follow-up period. At the 5-year follow-up no cases of recoarctation were 
identified on angiography or magnetic resonance imaging. In 86.5% (26/30) of the 
patients antihypertensive medication was either decreased or discontinued.
Conclusions: SI is an effective and safe alternative to conventional surgery for the 
treatment of adult patients with CoA.
10:00 a.m.
1005-52	 Long-Term	Effects	(up	to18	years)	of	Balloon	
Angioplasty	of	Coarctation	of	the	Aorta	on	Systemic	
Hypertension	and	Left	Ventricular	Hypertrophy	in	
Adolescents	and	Adults.
Walid Hassan, Mahmoud Awad, Mohamed Eid Fawzy, Walid AL Habeeb, Fayez ElShaer, 
Shahid Malik, Mohamed Al Amri, Mohamed Shoukri, King Faisal Specialist Hospital and 
Research Center, Riyadh, Saudi Arabia
Background: To define the long-term effect of balloon angioplasty (BA) of aortic 
coarctation (AC) on systemic hypertension and left ventricular hypertrophy (LVH) in 
adolescent and adult patients.
Methods: Follow-up data of 53 patients (mean age 24 ± 9 years) undergoing BA for discrete 
AC at median interval of 11.8 years (range 4-18 years) including cardiac catheterization, 
MRI and Echocardiography form the basis of this study. Patients were divided into two 
groups (A&B) based on whether or not long-term antihypertensive therapy was required.
Results: No early or late deaths occurred. Fifty-one patients had baseline hypertension, 
49 patients had baseline LVH (92%), BA produced an immediate reduction in peak AC 
gradient from 66 ± 23 mmHg (95% confidence interval [CI]: 59.5 to 72.7) to 10.8 ± 7 mmHg 
(95% CI: 8.8 to 12.5) (p< 0.0001). Follow-up catheterization 12 months later revealed a 
residual gradient of 6.2 ± 6 mmHg (95% CI: 4.4 to 7.9) (p<0.001). The Doppler gradient 
across coarctation decreased from 59.6 ± 17 to 16 ± 8.4 mmHg at one year and 12.0 ± 
6.9 mmHg at last follow-up. Left ventricular mass index (LVMI) decreased significantly in 
48 patients (98%) from 132 ± 30.7 (95% CI: 122 to 141.9) to 86 ± 19.9 gram/m2 (95% CI: 
79.5 to 92.5)(p<0.0001). The systolic blood pressure decreased from 165 ± 17 mmHg 
(95% CI: 159 to 171) to 125 ± 10 mmHg (95% CI: 122 to 131, p<0.001) in 40 patients 
(group A) and from 184 ± 19 mmHg (95% CI: 169 to 198) to 142 ± 22 mmHg (95% CI: 
124 to 156, p<0.001) in 11 patients (group B). The blood pressure had normalized without 
medication in 40 (78%) of the 51 patients (165 ± 17 mmHg to 115 ± 10 mmHg).
Conclusions: (1) Long-term results of BA for discrete AC are excellent and should be 
considered as first option for treatment of this disease; (2) Regression of LVH (≥ 20% 
reduction in LVMI) occurred in 98% of patients after BA and only 22% of patients required 
medications for hypertension.
10:00 a.m.
1005-53	 Early	Transesophageal	Echocardiography	
After	Transcathether	Occlusion	of	Interatrial	
Communications	Allows	Timely	Detection	and	
Treatment	of	Intracardiac	Thrombus	Formation
Francesco Pelliccia, Antonino Granatelli, Christian Pristipino, Cinzia Cianfrocca, 
Vincenzo Pasceri, Giulio Speciale, Adriana Roncella, Giuseppe Richichi, San Filippo 
Neri Hospital, Rome, Italy
Background: Transcatheter closure for atrial septal defect (ASD) and patent foramen 
ovale (PFO) is an effective alternative to surgery or anticoagulant therapy. Thrombus 
formation on the device is the major concern with these implants and therefore 
transesophageal echocardiography (TEE) is usually scheduled 30 days and 6 months 
after the procedure. However, cerebrovascular events have been reported in some cases 
soon after implantation. Accordingly, the aim of this study was to verify if early TEE could 
improve detection and management of thrombus formation.
Methods: From August 2004 to July 2006, 43 patients (33±13 years) with PFO (N=30) or 
ASD (N=13) were treated with the Amplatzer device (N=33) or the Premere device (N=10). 
All were pre-treated with aspirin (81 to 325 mg/day) and clopidogrel (75 mg/day). TEE was 
used to guide the procedure. Heparin was given to achieve and maintain an actived clotting 
time of >300 s. Patients were discharged on dual antiplatelet therapy. TEE was performed 
<1 hour after the end of the procedure, at 30-day and 6-month follow-up visits.
Results: Device implantation was successful in all patients but one who had a dislocation 
of the Premere device and underwent surgery. Periprocedural complications included 
pericardial effusion (N=1), arrhythmias (N=4) and transient ST-segment elevation (N=3). 
Early TEE revealed a pedunculated and mobile thrombus attached at the left side of the 
Amplatzer device in 2 patients and of the Premere device in 1 patient. All cases were 
promptly treated by thrombolytic therapy with full-dose tenecteplase (0.53 mg/kg in 5-10 
s) with disappearance of thrombus in 15 to 60 min. Multivariate analysis did not show any 
significant predictor of a higher thromboembolic risk. TEE performed at 30 days and 6 
months did not show any other thrombus formation in any patient. No cerebrovascular 
event was recorded during a follow-up of 311±135 days.
Conclusions: (1) Thrombus formation on interatrial closure devices can occur soon 
after device implantation; (2) Early thrombus formation can be easily diagnosed provided 
that TEE is perfomed soon after the procedure; (3) Systemic thrombolysis is a safe and 
effective treatment of acute thrombus formation.
10:00 a.m.
1005-54	 Long-term	Results	(18	Years)	Of	Balloon	Angioplasty	
For	Discreet	Coarctation	Of	The	Aorta,	Comparison	
With	The	Reported	Series	Of	Stenting
Mohamed Eid Fawzy, Walid Hassan, Hassan ElWidaa, Suleiman Kharabsheh, Aly Al Sanei, 
Charles C. Canver, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Background: This study evaluated the long term follow up results up to 18 years of 
balloon angioplasty (BA) of discrete coarctation and an attempt to compare the results 
with the reported series of stenting of coarctation.
Methods: 53 patients (mean age, 23 ± 7 years) undergoing BA for discrete AC and followed-
up for 2-18 (mean 12 ± 4.4) years. The patients underwent repeat catheterization at one 
year, Magnetic Resonance Imaging (MRI) and Doppler echocardiography annually for up to 
18 years. Comparison with reported series of stenting of coarctation will be discussed.
Results: No early or late deaths occurred. BA produced a reduction in peak AC gradient 
from 66 + 23 mm Hg to 10.8 + 7 mm Hg (P< 0.0001). Follow-up catheterization 12 months 
later revealed a residual gradient of 6.2 + 6 mm Hg (P<0.001). Three patients (6.4%) 
with suboptimal initial outcome with peak gradient > 20 mm Hg had successful repeat 
angioplasty. Aneurysm developed at the site of dilation in 4 pts (6.4%). MRI follow-up 
results revealed no new aneurysm or appreciable changes in the size of preexisting 
aneurysms and no recoarctation was observed, no appreciable changes in the Doppler 
gradient across the AC site were noted. The blood pressure had normalized without 
medication in 33 (62%) of the 53 patients. Comparing the balloon angioplasty results with 
reported series of stenting did no show any advantage of stenting.
Conclusions: (1) Long-term results up to 18 years of BA for discrete AC are excellent 
and should be considered as first option for treatment of this disease; (2) and accordingly, 
we do not need to stent discrete AC.
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1203-256	 Right	Ventricular	Mechanical	Dyssynchrony	in	Children	
With	Hypoplastic	Left	Heart	Syndrome:	A	Target	for	
Cardiac	Resynchronization	Therapy?
Mark K. Friedberg, Norman H. Silverman, Anne M. Dubin, David N. Rosenthal, Stanford 
University, Palo Alto, CA
Mechanical dyssynchrony (MD) predicts response to cardiac resynchronization therapy 
(CRT) in adults with left ventricular (LV) failure. Children with hypoplastic left heart 
syndrome (HLH) may have right ventricular (RV) failure; however, RV MD has not been 
studied in HLH.
Methods: We used vector velocity imaging (VVI, Siemens, CA) to quantify the standard 
deviation (SD) of time to peak velocity, strain (S) and strain rate (SR) between 6 RV 
segments to define intraventricular RV MD in 16 children with HLH and RV and LV MD 
in 16 healthy age-matched controls. Comparisons were made by t-test or ANOVA as 
appropriate. RV systolic function was assessed by fractional area of change (FAC%). 
The relation between electrical (ED) and mechanical dyssynchrony and between MD and 
systolic function was assessed by linear regression.
Results: Cntrls and HLH were well matched for age (4.9±4.6 vs 4.8±4.4, NS). HLH pts 
had RV MD compared to both RV and LV of cntrls, as evidenced by S and SR VVI (Table). 
SD of time to peak S was similar in HLH pts after stage 2 vs stage 3 palliation (31±30 vs 
40±35 msec, NS) and between HLH pts that had B-T shunt vs RV-PA conduit for stage 
1 (37±38 vs 26±36 msec, NS). There was no relation between SD of time to peak S and 
RV FAC% in HLH (r=0.44, p=0.09). RV MD was similar in HLH pt with QRS < median (44 
msec) vs QRS > median (SD time to peak S: 45±34 vs 28±36, NS; SD time to peak SR: 
31±34 vs 30±41, NS).
Conclusions: Children with HLH have RV MD unrelated to ED. In HLH, RV MD may 
contribute to RV dysfunction and may be a therapeutic target for CRT.
Mechanical Dyssynchrony in Children with HLH and in Age Matched 
Controls
Hypoplastic	Left	
Heart	Syndrome:	
Right	Ventricle
Controls:
Left	
Ventricle
p
Controls:
Right	
Ventricle
p
Standard	Deviation	of	Time	to	
Peak	Velocity	(msec) 43±67 11±6 0.07 12±7 0.08
Standard	Deviation	of	Time	to	
Peak	Strain	(msec) 37±35 8±8 <0.01 9±11 <0.01
Standard	Deviation	of	Time	to	
Peak	Strain	Rate	(msec) 31±37 10±13 <0.05 14±15 0.09
Noon
1203-257	 Minimal	Interstage	Mortality	With	the	Hybrid	Procedure	
for	Hypoplastic	Left	Heart	Patients
Clifford L. Cua, Bernadette Fenstermaker, Glen E. Berger, Vincent F. Olshove, John P. 
Cheatham, Mark E. Galantowicz, Columbus Children’s Hospital, Columbus, OH
Background: The hybrid procedure consisting of bilateral pulmonary artery bands, 
ductus arteriosus stent, and atrial septostomy has been proposed as an alternative for 
initial palliation of patients with hypoplastic left heart syndrome (HLHS). Data for this 
procedure are available, but minimal information about morbidity and mortality exists for 
the inter-stage (IS) period. The goal of this study was to report our IS experience with 
patients who have undergone the hybrid procedure.
Methods: Retrospective chart review was performed on all patients discharged from the hospital 
with the diagnosis of HLHS who underwent the hybrid procedure. Patients were excluded if they 
had a HLHS variant or if they had not undergone the second stage procedure.
Results: Between July 2002 to September 2006, 28 patients met inclusion criteria. Four 
patients had a restrictive atrial septum requiring septostomy before the hybrid procedure. 
Age at hybrid procedure was 11.3 + 15.8 days and weight was 3.0 + 0.6 kg. Eleven 
patients had one additional catheterization intervention, two patients had two additional 
interventions, and one patient had three additional interventions. Two patients had one 
additional surgical procedure. One patient had replacement of a loose pulmonary artery 
band and the other had an enlargement of the pulmonary veins. Age at stage II was 167.7 
+ 62.0 days and weight was 5.6 + 1.1 kg. IS mortality was 7.1% (2/28). One death was 
sudden and unexpected while the second death occurred in a patient with progressive 
pulmonary vein stenosis.
Conclusions: There was minimal IS mortality for the hybrid procedure. The hybrid 
IS mortality compares favorably to the reported mortality for the classic and modified 
Norwood procedures. Further large randomized studies are needed to determine whether 
these results remain consistent.
Noon
1203-258	 Survival	Through	Fontan	Completion	After	Stage	One	
Palliation	With	Either	a	Right	Ventricle	to	Pulmonary	
Artery	Conduit	or	Modified	Blalock-Taussig	Shunt
Mark A. Scheurer, Josh W. Salvin, Vladimiro L. Vida, Francis Fynn-Thompson, Emile A. 
Bacha, Frank A. Pigula, John E. Mayer, Jr., Pedro J. del Nido, Peter C. Laussen, Ravi 
R. Thiagarajan, Children’s Hospital Boston, Boston, MA
Background: Although improved surgical and interstage survival have been demonstrated 
in some series with the use of the right ventricle to pulmonary artery (RV-PA) conduit at 
stage one palliation (S1P), it is unknown whether this improved survival will continue 
through long term follow-up. 
Methods: All patients who underwent a S1P in 2002 and 2003 (n=80) at our institution 
were included for analysis. Each patient was followed until death, loss to follow-up or 
September 1, 2006. Outcome variables at the time of Fontan at our institution were 
recorded. Groups classified by source of pulmonary blood flow at S1P were compared. 
Results: Survival for the entire cohort was 79.4% at one year and 72.3% at 4.5 years. For 
the patients who underwent a RV-PA conduit during S1P (n=33), survival at one year was 
81.7% and 78.6% at 4.5 years compared to 77.7% at one year and 68.1% at 4.5 years for 
those who underwent a Blalock-Taussig shunt (BTS) (n=47) (log-rank = 0.44). Previous 
work has shown improved interstage survival at Glenn in this cohort for those with a RV-PA 
conduit. At Fontan (n=39), when compared to those who had a BTS placed at S1P, those 
who had a RV-PA conduit had a decrease in duration of ventilation [20 hrs (10-80) vs. 26.5 
(7-204), p=0.04] and ICU stay [2 days (1-6) vs. 4 (1-25), p=0.04]. No differences in inotrope 
score [19.5 (4.5-119.5) vs. 17 (9.5-52), p=0.83], amount of chest tube output in the first 
48 hours [35.4cc/kg/day (8.2-109.4) vs. 35.3 (14-117.5), p=0.91] or length of hospital stay 
[10 days (5-29) vs. 10 (6-48), p=0.93] were found between the two groups. Multivariable 
analysis of perioperative S1P variables found variant of hypoplastic left heart anatomy 
[hazard ratio (HR) 3.4 (95% CI 1.2 - 10.2) (p=0.03)], need for post-operative ECMO [HR 5.5 
(1.9 - 15.6) (p<0.001)] and peritoneal dialysis [HR 5.6 (1.5 - 21.5) (p=0.01)] as independent 
risk factors for death through the period of Fontan completion.
Conclusion: In this cohort, there was no association found between the source 
of pulmonary blood flow created at S1P and survival through the period of Fontan 
completion. Besides decreases in duration of ventilation and ICU stay, there were no 
differences in clinical course at the Fontan procedure between the two groups. 
Noon
1203-259	 Atrial	Septal	Defects	Versus	Ventricular	Septal	
Defects	in	BREATHE-5,	a	Placebo-Controlled	Study	
of	Pulmonary	Arterial	Hypertension	Associated	With	
Eisenmenger	Syndrome:	A	Subgroup	Analysis
Rolf Berger, Maurice Beghetti, Nazzareno Galie, Michael A. Gatzoulis, John Granton, 
Andrea Lauer, Eleonora Choissi, Michael Landzberg, University Medical Center 
Groningen, Groningen, The Netherlands
Background:	Evolution of pulmonary vascular disease, ventricular loading conditions 
and natural course differ importantly between Eisenmenger syndrome (ES) patients with 
pretricuspid shunts compared to those with posttricuspid shunts. It has been suggested 
therefore that response to bosentan, a dual endothelin receptor antagonist, may differ 
in these patient groups. Pretricuspid-ES may respond positively, similar to patients with 
idiopathic pulmonary arterial hypertension, whereas posttricuspid-ES may have lesser 
clinical benefit and be at risk for desaturation. In BREATHE-5, the first randomized, 
placebo-controlled study in ES, bosentan improved hemodynamics and exercise capacity 
with no adverse effect on oxygen saturation (SpO2). Patients with atrial septal defects 
(ASDs) or ventricular septal defects (VSDs) were included. The purpose of this subgroup 
analysis was to determine if ASD data drove the overall positive study results.
Methods: This 16-week study included ES patients with ASDs ≥2 cm in diameter and VSDs 
≥1 cm, and hypoxia (SpO2 between 70-90%). Methods have been described previously.
Results: Five ASD patients were randomized to placebo, 8 to bosentan. 12 VSD patients 
were randomized to placebo, 29 to bosentan. PVRi: after 16 weeks, bosentan treatment 
effect for ASDs was -542.0 (S.E. 405.4) dyn·sec·cm-5, 95% CI=[-1434.4, 350.3]; for VSDs, 
-412.3 (S.E. 263.9) dyn·sec·cm-5, 95% CI=[-946.4, 121.9]. mPAP: Treatment effect for 
ASDs was -11.2 (S.E. 5.6) mmHg, 95% CI=[-24.0, 1.6]; for VSDs, -3.6 (S.E. 2.9) mmHg, 
95% CI=[-9.4, 2.2]. 6MWD:	Treatment effect for ASDs was 89.7 (S.E. 55.5) m, 95% CI=[-
32.3, 211.8]; for VSDs, 35.3 (S.E. 16.9) m, 95% CI=[1.0, 69.5]. No adverse effects on 
SpO2 were observed in both groups.
Conclusions: Improvements in hemodynamics without desaturation were found in both 
ASD and VSD subgroups that were of similar magnitude as the primary analysis. The 
6MWD, of greatest clinical relevance, showed a positive trend in the ASD group, and 
maintained a treatment effect in the VSD group. These subgroup analyses results confirm 
that the inclusion of ASDs did not confound the positive results of BREATHE-5 which 
comprised mainly VSDs with severe PAH.
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1203-260	 Valve	Competence	1Year	After	Percutaneous	Pulmonary	
Valve	Implantation	or	Surgical	Homograft	Implantation	
Assessed	by	Magnetic	Resonance	Imaging
Johannes Nordmeyer, Alessandra Frigiola, Philipp Lurz, Louise Coats, Wendy Norman, 
Orla Franklin, Philipp Bonhoeffer, Andrew Taylor, UCL Institute of Child Health and Great 
Ormond Street Hospital for Children, London, United Kingdom
Background: Percutaneous pulmonary valve implantation (PPVI) is an alternative to 
repeat surgical homograft implantation. Valve competence over time has implications 
for the need of re-intervention. Many homografts used for congenital heart surgery 
degenerate and develop regurgitation. We sought to compare their valve competence 
with PPVI one year following intervention.
Methods: We investigated 32 PPVI patients (mean age 23±11 years) and 25 patients 
(mean age 21±13 years), who underwent homograft implantation in the pulmonary 
position. One year following intervention, the pulmonary valve competence was assessed 
using magnetic resonance (MR) imaging. Pulmonary flow was calculated from the phase-
contrast images and the regurgitant fraction (PRF) was calculated as the percent backward 
flow over forward flow. A PRF of > 20% was judged significant regurgitation. Fisher’s 
exact test was used and a P-value of < 0.05 was considered statistically significant.
Results: One year following intervention, more patients in the surgical group had 
significant pulmonary regurgitation compared to the PPVI group (P=0.013, Table).
Conclusions: Significant pulmonary regurgitation is common in surgical patients, one 
year following homograft implantation. Valve incompetence in this population is likely 
due to distorted homograft valves in complex anatomy. The leaflet mobility of the bovine 
jugular vein used in PPVI leads to superior competence at one year.	
Table
PRF < 20%, 1year post 
intervention
PRF > 20%, 1year post 
intervention
Statistical 
Significance
Surgery
[n=25] 20 patients 5 patients
PPVI
[n=32] 32 patients 0 patient P=0.013
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1011-27	 Radiation	Risks	Related	to	Pediatric	Catheter	Ablation
Mark Clay, Robert M. Campbell, Margaret J. Strieper, Patricio A. Frias, William T. Mahle, 
Sibley Heart Center, Children’s Healthcare of Atlanta & Emory University School of 
Medicine, Atlanta, GA
Background: Children undergoing radiofrequency ablation (RFA) are thought to be at 
increased risk for developing malignancy due to radiation; though the magnitude of this 
risk is incompletely understood.
Methods: We have previously reported a strategy to reduce radiation exposure during 
pediatric RFA. In a cohort of 15 subjects (median age 12 yrs, range: 9-17 yrs) radiation 
was measured with dosimeters at 5 sites. We calculated risk of malignancy using 
measured radiation absorbed dose. International Council for Radiation Protection (ICRP 
60) risk estimates were applied to calculate absorbed organ doses.
Results: The median duration of combined bi-plane fluorscopy was 14.4 minutes. 
Among the 5 dosimeter locations the right scapular location had the highest median 
radiation exposure, 43 miligray (mGy). Incorporating data from the 5 dosimeters the risk 
model calculated that the organ with greatest absorbed dose--and at greatest risk for 
malignancy--was the lung, followed by bone marrow, then breast(table). Thyroid and 
ovary exposures were negligible. The increased lifetime risk of fatal malignancy was 
0.02% per single RFA procedure.
Conclusions: With appropriate measures to reduce radiation exposure the increased 
risk of malignancy following a single RFA procedure in children is quite low. These data 
should be of help in counselling families and will contribute to analysis of the relative 
benefits of novel imaging approaches such as a magnetic resonance imaging-based 
catheterization laboratory.
Risk of Malignancy With Pediatric RFA
Organ Absorbed Dose (mGy)
Excess Risk of Malignancy 
(/million pts)
% Increased Risk of Fatal 
Malignancy
Lung 11.1±6.5 103±64 0.02%
Bone 
marrow
1.6±0.8 9±5 0.001%
Breast 1.6±0.7 3±2 0.0005%
Total Risk ..... 114 0.02%
2:30 p.m.
1011-28	 Extracardiac	Fontan	Demonstrates	Lower	Power	Loss	
Compared	To	Intracardiac	Fontan	-	A	Computational	
Fluid	Dynamics	Study
Kevin K. Whitehead, Kerem Pekkan, Ravi Doddasomayajula, Hiroumi D. Kitajima, 
Kartik S. Sundareswaran, Ajit P. Yoganathan, Mark A. Fogel, Children’s Hospital of 
Philadelphia, Philadelphia, PA, Georgia Institute of Technology, Atlanta, GA
Background: Determining whether intracardiac or extracardiac Fontans are more 
hemodynamically favorable has been elusive clinically. One characteristic which may 
distinguish the two is power loss, which we have demonstrated previously can be 
accurately estimated using computational fluid dynamic (CFD) analysis.
Hypothesis: It is our hypothesis that the extracardiac Fontan is more hemodynamically 
favorable compared to the lateral tunnel Fontan, due to decreased vortex formation, 
decreased flow collision, less eccentric flow and thus lower viscous dissipation.
Methods: We performed steady flow CFD simulations on 3-D anatomical reconstructions of 
total cavopulmonary connections (TCPC) from 11 Fontan patients using cardiac magnetic 
resonance imaging (CMR) data, 5 with extracardiac (EC) and 6 with lateral tunnel intracardiac 
(IC) Fontans. Caval flows were determined using CMR velocimetry and outlet pressures were 
tuned for both the left and right pulmonary arteries in order to yield three different flow splits: 
equal flow to each lung, equal lung resistance of 2 Woods units, and CMR-measured. Power 
loss calculations using control volume analysis were performed for each TCPC and each 
flow condition studied. Power losses were normalized to cardiac output and the two groups 
compared using the Student t-test for two independent groups.
Results: The lowest power losses were seen in the equal lung resistance condition, where 
power loss in the EC TCPC was 0.91±0.70 mW/l/min, compared to 3.3±1.3 mW/l/min for the IC 
TCPC. Power losses were similar for the other flow conditions. This difference between EC and 
IC TCPC was statistically significant for each flow split studied (p<0.01 for all splits studied).
Conclusions: CFD modeling of 3-D anatomical reconstructions demonstrates differences 
in power loss between EC and IC TCPC, indicating that the EC Fontan may be more 
energetically favorable. More studies are required to determine whether these differences 
are universal. These differences may be important in the long-term survival and quality 
of life of patients with TCPC.
2:30 p.m.
1011-30	 Fetal	Ductal	Constriction	Triggered	by	Maternal	
Ingestion	of	Polyphenol-Rich	Common	Beverages:	
a	Clinical	Approach
Paulo Zielinsky, Antonio L. Piccoli Jr, João L. Manica, Luiz H. Nicoloso, Honório S. 
Menezes, Renato Frajndlich, Rafaella Petracco, André Busato, Laura Hagemann, Marina 
Moraes, Julia Silva, Institute of Cardiology of Rio Grande do Sul / FUC, Porto Alegre, Brazil
Background: Inhibition of circulating prostaglandins may promote fetal ductal constriction, 
especially in late gestation, The hypothesis that maternal consumption of widely used 
polyphenol-rich substances, such as herbal teas and grape juice during pregnancy could 
be associated to fetal ductal constriction, as a result of prostaglandin inhibition-mediated 
antiinflammatory effects of the catechin components of these beverages, has been formulated. 
This study shows clinical evidences pointing toward corroboration of this hypothesis.
Methods: A review of a series of 92 fetuses with ductal constriction has been performed. 
A cohort of the last 31 cases, sequentially seen after this hypothesis was brougt up, in 
late 2005, made up the basis for this report. Differences were analyzed by Wilcoxon test 
and associations were tested by Fisher´s exact test.
Results: In 24 fetuses out of 34 beyond 30 weeks with ductal constriction (77 %), there was 
evidence of maternal ingestion of polyphenol-rich beverages (green tea, mate tea, Indian tea, 
boldine tea and grape juice). Immediate discontinuation of these substances was reccomended, 
and a control echocardiogram was obtained after 1 to 3 weeks in 11 fetuses. Of these, 10 
(91%) showed important improvement or complete recovery of the signs of ductal constriction. 
A decrease in mean ductal systolic velocity (1.74 ± 0. 25 m/s to 1.34 ± 0.29 m/s, p=0.005) and 
mean diastolic velocity (0.38 ± 0.09 m/s to 0.22 ± 0.03 m/s, p =0.0001, with an increase in 
mean ductal pulsatility index (1.60 ± 0.43 to 2,14 ± 0.28, p=0.001) were observed. Only one of 
the 7 fetuses with other triggering factors (nonsteroidal antiinflammatory drugs, corticosteroids, 
paracetamol) improved in the same period. Out of the 11 fetuses with improvement in the 
control echo, 10 (91%) were in the polyphenol group. There was significant association between 
improvement and polyphenol discontinuation (p=0.005).
Conclusions: Maternal ingestion of substances containing polyphenols is very 
common in fetuses with ductal constriction and discontinuing these beverages results in 
improvement in the vast majority of cases.
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1011-31	 Green	Tea	and	Mate	Tea	Cause	Fetal	Ductal	
Constriction:	an	Experimental	Study
Paulo Zielinsky, José C. Areias, Antonio L. Piccoli Jr, João L. Manica, Luiz H. Nicoloso, 
Honório S. Menezes, Renato Frajndlich, Rafaella Petracco, André Busato, Laura 
Hagemann, Marina Moraes, Julia Silva, Institute of Cardiology of Rio Grande do Sul / 
FUC, Porto Alegre, Brazil, Hospital São João, University of Porto, Porto, Portugal
Background: The role of maternal ingestion of nonsteroidal antiinflammatory drugs in 
triggering fetal ductal constriction, a potential predisposing factor for neonatal pulmonary 
hypertension, is related to inhibition of circulating prostaglandins. Herbal teas widely used 
in pregnancy, such as green tea and mate tea, have polyphenol components, especially 
3-gallate-gallocatechin, with antioxidant and antiinflammatory effects depending on 
inhibition of ciclooxigenase-2. This study was designed to test the hypothesis that 
maternal consumption of green tea and mate tea is associated with the genesis of fetal 
ductal constriction.
Methods: Eight near term fetal lambs were assessed by fetal Doppler echocardiography 
with color flow mapping, before and one week after maternal administration of 
concentrated dosages of green tea to four sheep and mate tea to the other four as the 
only source of liquid. Differences were compared by Wilcoxon test.
Results: In all eight fetuses inequivocal evidences of constriction of ductus arteriosus 
were demonstrated, with increase in mean ductal systolic velocities (0.80 ± 0.19 m/s to 
1.17 ± 0.15 m/s, p=0.018), mean diastolic velocities (0.21 ± 0.05 m/s to 0.31 ± 0.01 m/s, 
p=0.018) and mean right to left ventricular dimension ratios (1.05 ± 0.14 to 1.43 ± 0.23, 
p=0.02), as well as ductal flow turbulence, leftward ventricular septal bulging and tricuspid 
regurgitation in all. Pulmonary regurgitation was present in 2 fetuses. There was 1 fetal 
death, with a dilated and hypertrophic right ventricle being shown at autopsy.
Conclusions: This experimental study provides evidences that maternal administration 
of the polyphenol-rich beverages green tea and mate tea at late gestation is associated 
with constriction of fetal ductus arteriosus. This knowledge should pompt preventive 
actions in perinatal dietary orientation.
2:30 p.m.
1011-32	 Heparin	Therapy	in	Protein	Losing	Enteropathy	
Associated	With	Single	Ventricle	Palliation
Lindsay M. Ryerson, Caren S. Goldberg, Amnon Rosenthal, Aimee K. Armstrong, 
University of Michigan, Ann Arbor, MI
Background: Protein losing enteropathy (PLE) affects 4-13% of Fontan operative 
survivors. Five year survival, after the onset of PLE, is only 46-59%.	
Methods: We studied a cohort of patients with single ventricle palliation who developed 
PLE and were treated with subcutaneous heparin. PLE was defined by the presence of 
symptoms and elevated fecal alpha-1-antitrypsin (FA1AT >200mg/dL) and/or persistently 
low serum albumin (<3.0g/dL). Information collected included demographics, cardiac 
anatomy, type of Fontan procedure, baffle fenestration status, symptoms before and after 
heparin therapy, catheterization and laboratory data, x-ray and bone density studies, and 
the number of hospitalizations and albumin infusions prior to and for one year after the 
initiation of heparin.
Results:	Seventeen patients were included in the study. Mean follow-up time on heparin 
was 54 months (range 5-126). Symptoms of PLE appeared 48 months (range 3-182) 
after surgical palliation. At diagnosis of PLE, mean albumin was 2.0 +/-0.4 g/dL (range 
1.6-2.9) and 60% of patients had FA1AT checked (range 148-1621mg/dL). At cardiac 
catheterization (n=13), prior to starting heparin therapy, mean systemic venous pressure 
was 11.6mmHg (range 7-17). Period from onset of PLE to initiation of heparin was a mean 
of 17 months (median of 4 months). Subjective improvement on heparin therapy occurred 
in 13/17 patients (76%). Duration of PLE symptoms prior to initiation of heparin was a 
mean of 15.5 months (range 1-75) in the improved patients and 27.8 months (range 1-77) 
in the four patients with no symptomatic improvement	(p=0.47). Compared to the period 
prior to initiation of heparin, there was no significant difference in the number of hospital 
admissions (p=.56) or albumin infusions (p=.88) in the first year of heparin therapy. Five 
patients had thoraco-lumbar spinal x-rays, and eight patients had bone mineral analyses 
of the lumbar spine and femoral neck; all scans were grossly abnormal.
Conclusions: Subcutaneous heparin therapy leads to subjective improvement of PLE 
symptoms but does not change the need for frequent albumin infusions. Osteopenia and 
osteoporosis are common complications of heparin therapy.
2:30 p.m.
1011-33	 Developmental	Changes	in	the	Modulation	of	Contractility	
in	Human	Ventricle
Carlo M. Zeidenweber, Rob F. Wiegerinck, Anca Cojoc, Essie M. Potts, Guoliang 
Ding, Ronald W. Joyner, Mary B. Wagner, Emory University, Atlanta, GA, Chidren’s 
Healthcare of Atlanta, Atlanta, GA
Background: Contractility and relaxation rate have been shown to increase with postnatal 
age in mammalian ventricle, although very few studies have measured contractions in human 
infant ventricle. This study examines the developmental changes in the effects of sympathetic 
stimulation and response to stimulation frequency in human ventricle over the first year of life.
Methods: Isometric developed tension was measured in right ventricular muscle strips 
obtained from human biopsies, including five tissue strips from newborn patients (< 1 
week old) undergoing palliation for hypoplastic left heart syndrome with a right ventricle to 
pulmonary artery shunt, and three tissue strips from infants (3-12 months old) undergoing 
repair for Tetralogy of Fallot. Stimulation was performed at different pacing cycle 
lengths (CL) to determine the force frequency relationship (FFR) in control, with 100 nM 
isoproterenol and with 10 µM forskolin. Protein levels of Na/Ca Exchanger (NCX) and SR 
Ca-atpase (SERCA) were determined in the same age populations.
Results: The response to isoproterenol was significantly smaller in newborn human 
ventricle compared to infant (152 ± 6% vs. 274 ± 52%, p<0.05). The newborn also had a 
significantly smaller response to forskolin compared to infants (183 ± 11% vs. 382 ± 69%, 
p<0.05). Compared to forskolin, isoproterenol was not able to maximize the contraction 
in either age group. The newborn had a flat FFR, with no increase in developed force 
at faster rates of pacing. In contrast, the infant had a significant positive FFR. There 
was a significant correlation between NCX levels and increasing age (p=0.003) while 
SERCA levels were unchanged between newborns and older infants. Conclusion:	This 
study shows for the first time that the newborn human ventricle, in addition to having 
reduced response to sympathetic stimulation, also has a blunted FFR. This suggests that 
in humans, contractile reserve is limited at birth and increases over the first year of life. 
Whether these findings are primarily due to higher levels of NCX in the newborn period 
needs to be determined.
2:30 p.m.
1011-48	 Can	an	Outpatient,	Physician-driven	Approach	to	Weight	
Loss	Work	in	an	Overweight,	Dyslipidemic	Pediatric	
Population	With	Characteristics	of	Metabolic	Syndrome
Brad A. Friedman, Stanley J. Goldberg, University of Arizona, Tucson, AZ
Background: Minimal data exist on office-based methods to accomplish weight loss 
and improve lipids in overweight, dyslipidemic children with characteristics of metabolic 
syndrome (MS). Our purpose was to assess the efficacy of a standardized outpatient 
office-based intervention for accomplishing weight reduction in such a population using a 
limited set of dietary and exercise instructions. The hypothesis was that this intervention 
would cause significant decreases in % body-mass index (BMI), BMI z-score, and 
triglycerides, and an increase in HDL.
Methods: A retrospective study was conducted of 84 consecutive pediatric patients (mean 
age 12.5 years) with a BMI of greater than the 85th percentile referred to a dyslipidemia 
clinic between 2001 and 2004. 88% had 2 or more criteria for MS and 63% met 3 or more 
criteria for MS. During the initial and subsequent office visits, the physician gave all patients 
specific, standardized recommendations for diet and exercise modification. The diet 
consisted of restricting daily caloric intake to 1800 Kcal/d. Caloric beverages and deep-fried 
foods were eliminated. School children were instructed to bring lunch to school to control 
caloric intake. Aerobic exercise was recommended for 30 minutes or more daily.
Results: After a mean duration of 1.4 years on diet and exercise modification, the 
population demonstrated mean decreases in % BMI (96.5% to 93.5%, p <.0001) and 
BMI z-score (1.98 to 1.8, p <.0001). Mean total cholesterol dropped from 205 mg/dl to 
192 mg/dl (p < .02), and mean triglycerides decreased from 208 mg/dl to 141 mg/dl (p < 
.03). HDL did not increase significantly (43 to 44 mg/dl). Blood pressure did not change 
significantly. Mean weight loss was not affected by differences in socioeconomic status, 
ethnicity, gender, or age at study onset. Patients with 3 or more follow-ups lost more 
weight than patients with only 2 visits (p < .0001).
Conclusions: A standardized, office-based intervention characterized by a limited set 
of dietary and exercise recommendations explained by the physician during office visits 
can be effective in accomplishing weight loss and improving lipid profiles in overweight, 
dyslipidemic pediatric patients with characteristics of MS.
2:30 p.m.
1011-49	 Dobutamine	Stress	Echocardiography	Is	Feasible,	
Efficacious,	and	Safe	in	the	Estimation	of	Right	Ventricular	
Reserve	in	Patients	With	Repaired	Tetralogy	of	Fallot
Stella Brili, Nikolaos Alexopoulos, John Barbetseas, Christina Chrysohoou, John 
Karamitros, Athanassios Bratsas, Ilias Stamatopoulos, Christodoulos Stefanadis, Athens 
Medical School, Hippokration Hospital, Athens, Greece
Background: The longstanding pulmonary regurgitation in patients with repaired 
Tetralogy of Fallot results in right ventricular (RV) failure. The estimation of RV function 
and reserve in these patients is of great importance, especially for the determination of 
the proper timing for pulmonary valve replacement. Tissue Doppler Imaging (TDI) of the 
tricuspid annulus has been proved a valuable tool in the investigation of these patients. 
Dobutamine stress echocardiography in low doses detects the reserve of cardiac 
myocytes to increase contractility. At this study we aimed at examining the feasibility, 
efficacy, and safety of dobutamine stress echocardiography in the evaluation of RV 
reserve in patients with repaired Tetralogy of Fallot, and to compare them with controls.
Methods: We studied 20 patients with repaired Tetralogy of Fallot (age 27.9±8.1 
years, 18.8±4.2 years after surgery) and 20 age- and gender- matched controls with 
TDI Doppler at the tricuspid annulus during dobutamine stress echocardiography. TDI 
measurements were made at baseline and at the peak of 3 min dobutamine infusion 
rates of 10 and 20 μg/Kg/min.
Results: All patients had pulmonary regurgitation (5 mild, 12 moderate, 3 severe) and 
tricuspid regurgitation (mild to moderate). As expected, patients had decreased TDI 
velocities at baseline compared to controls (Sa, 8.2±1.0 vs. 15.9±2.1; Ea, 8.8±3.0 vs. 
14.9±3.8; Aa, 5.8±1.8 vs. 13.2±1.9, p<0.001 for all). Although all patients and controls 
increased the Sa during dobutamine stress echocardiography, the percentage increase 
of Sa (Sa%) was less in patients compared to controls (41.5±11.1 vs. 56.8±17.4, p<0.01), 
denoting decreased RV systolic reserve. None of the patients or the controls had 
any adverse event, such as paroxysmal atrial tachycardia, ventricular tachycardia, or 
hypotension, during dobutamine stress echocardiography.
Conclusions: Dobutamine stress echocardiography is feasible, efficacious, and safe in 
the detection of RV reserve in patients with repaired Tetralogy of Fallot and may help in 
the evaluation and follow up of these patients in order to determine the optimum timing 
for pulmonary valve replacement.
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2:30 p.m.
1011-50	 New	Physiological	Classification	for	Surgical	
Management	of	Hypoplastic	Right	Ventricle	in	
Pulmonary	Atresia	With	Intact	Ventricular	Septum
Shuji Shimizu, Toshiaki Shishido, Kazunori Uemura, Atsunori Kamiya, Toru Kawada, 
Masaru Sugimachi, National Cardiovascular Center Research Institute, Osaka, Japan
Background: It is often difficult to select a surgical option for the patient with hypoplastic 
right ventricle (RV) in pulmonary atresia with intact ventricular septum. Although various 
authors have reported some strategies based on the morphologic characteristics such 
as RV end-diastolic volume (EDV), these values are dependent on loading conditions. 
Furthermore these strategies are not based on the postoperative physiological 
characteristics of this complex circulation. To clarify the postoperative physiological 
conditions, we performed the theoretical analysis in a computational model based on 
the lumped-parameter state-variable equations. These results may give insights into 
selection criteria among surgical options.
Methods: Computer models of the postoperative cardiovascular dynamics of total 
cavopulmonary connection (TCPC), one and a half ventricle repair (1.5VR) and biventricular 
repair (2VR) were developed. The modified three-element windkessel was assumed as 
vascular systems. Hypoplasitc RV was characterized by decreased RV compliance. RV 
diastolic pressure was described as a function of RV volume (P=Aexp(B·V)), where B 
was the reciprocal of compliance. We varied the value of B to simulate the changes in RV 
hypoplasticity. With this framework, we estimated RVEDV, right atrial pressure (RAP) and 
cardiac output (CO) for a given RV compliance.
Results: With RV compliance >60% of normal RV, CO was larger in 2VR than in 1.5VR and 
in TCPC. With RV compliance <=60%, CO became larger in 1.5VR than in 2VR. With RV 
compliance <40%, RVEDV of 1.5VR was almost equal to that of 2VR and RAP rapidly increased 
with decrease in compliance. In this range, the beneficial effects of RV obviously diminished.
Conclusions: We have shown, using model analysis, that we can classify patients 
into three groups by RV compliance. Theoretical analysis suggested that 2VR should 
be selected for mild hypoplasia with RV compliance >60% of normal RV, 1.5VR for 
intermediate hypoplasia with RV compliance between 40-60%, and TCPC for severe 
hypoplasia with RV compliance <40%. We should assess the pre-operative value of RV 
compliance for selection of one of these surgical options.
2:30 p.m.
1011-51	 Right	Ventricular	Function	in	Patients	With	
Eisenmenger	Physiology:	Insights	From	Two-
Dimensional	Strain	Echocardiography
Andreas P. Kalogeropoulos, Stamatios Lerakis, Matthew Mendez-Zfass, Neelima 
Tammareddi, Maria-Alexandra Pernetz, Sharon Howell, Stephen D. Clements, Jr., 
Randolph P. Martin, Emory University Hospital, Atlanta, GA
Background:	Patients with Eisenmenger physiology (ES) do better in terms of functional 
capacity and survival than patients with primary pulmonary hypertension (PPH). This 
is partially attributed to a unique adaptation of the right ventricle (RV) in ES. However, 
standard echocardiography (2D) has certain limitations in the evaluation of RV function.
Methods: We evaluated 19 patients with ES (49 ± 15 yrs, 6 male), 18 patients with 
PPH (47 ± 17 yrs, 4 male), and 22 outpatients without structural heart disease (45 ± 
14 yrs, 7 male). All underwent 2D, tissue Doppler (TD), and two-dimensional strain 
(2DS) echocardiography on a high-resolution system. We recorded longitudinal strain 
(shortening) of the RV free wall from apical 4-chamber views, as well as 2D and TD 
indices of RV function.
Results: RV systolic pressure was comparable between ES and PPH patients (82 ± 23 
vs. 84 ± 23 mmHg, p=NS). However, WHO class was worse in PPH patients (2.7 ± 0.5 
vs. 2.1 ± 0.5, p<0.01). The main 2D and TD findings are presented in the Table. In 2DS 
analysis, ES patients showed significantly higher RV free wall strain values compared 
to PPH patients (-18 ± 6 vs. -12 ± 5 %, p<0.01). Both patient groups had lower values 
compared to controls (-23 ± 5 %, p<0.01 vs. both).
Conclusion: Patients with ES show a similar decline in 2D and TD indices of RV function 
compared to PPH patients. However, 2DS data strongly suggest a more preserved RV free wall 
contractility in patients with ES, which might contribute to a relatively better clinical course. 
Table. Main 2D and TD echocardiographic findings.
Control	
(n=22) ES	(n=19)
PHT	
(n=18)
p	(ES	vs	
PPH)
LV Ejection Fraction (Biplane), % 63 ± 7 60 ± 9 67 ± 8 NS
RV Diameter (Mid-Level), mm 34 ± 9 42 ± 8* 46 ± 7* NS
RV Free Wall Thickness, mm 3.9 ± 0.8 7.5 ± 0.8* 7.1 ± 1.0* NS
RV Fractional Area Change, % 40 ± 7 27 ± 10* 23 ± 7* NS
RV Ejection Fraction (Area-
Length), % 54 ± 10 38 ± 16* 31 ± 10* NS
TD RV Systolic Velocity, cm/s 14.2 ± 3.0 10.0 ± 2.2* 11.6 ± 2.4* NS
TD RV Early Diastolic Velocity, 
cm/s 14.4 ± 1.8 8.2 ± 2.2* 9.8 ± 3.4* NS
* <0.01 vs. control
2:30 p.m.
1011-52	 Long-term	Intravenous	and	Subcutaneous	
Prostaglandin	Therapy	Outperforms	Oral	Endothelin	
Antagonism	in	Patients	with	Eisenmenger	Syndrome
Alfred V. Rathinam, Rapheal Ngengwe, Justin Ranes, Bashar S. Aldeen, Raed Dweik, 
Richard A. Krasuski, The Cleveland Clinic, Cleveland, OH
Background:	Eisenmenger syndrome (ES) is an unusual complication of intracardiac shunt and 
results in numerous medical complications. Recent studies have suggested a role for vasodilator 
therapy. The long-term efficacy of available therapies has not been directly compared.
Methods: We examined the therapeutic response to vasodilator therapy in a cohort of 
ES patients. All patients underwent baseline right heart catheterization. Median follow-up 
was 48 months and follow-up testing included measurement of plasma brain natriuretic 
peptide (BNP) and 6-minute walk testing (6MW) at 3 to 6 month intervals.
Results:	Twenty-seven consecutive patients were referred for consideration of vasodilator 
therapy over a 6-year period, including 11 ventricular septal defects, 9 atrial septal defects, 
3 atrioventricular canal defects, and 2 patent ducti. The mean age was 39±14 years, 
78% were women, mean BNP level was 146±226 pg/ml and NYHA function class was 
2.8±0.7. Mean pulmonary artery pressure at baseline was 57±14 mm Hg, cardiac index 
2.8±1.1 l/min, and pulmonary vascular resistance 13.3±8.6 Wood U. Eleven patients were 
treated with intravenous or subcutaneous prostaglandins (PG), 11 patients received oral 
endothelin antagonists (EA), 3 were treated with calcium channel blockers and 2 received 
no vasodilator. During follow-up 1 patient treated with PG stopped therapy and 3 had 
EA added. Among EA patients, one was later started on PG. No baseline differences 
were noted between PG and EA treated patients. No significant alteration in BNP levels 
was noted with either therapy and no major complications were noted during follow-up. 
Though minimal change in 6MW was noted during follow-up with EA: 362±84 meters at 
baseline, 370±88 at ~6 months and 386±116 at ~2 years (p=0.589 and 0.351 respectively); 
significant improvements were noted in the PG-treated group, 371±86 at baseline, 426±57 
at ~4 months and 472±129 at ~3 years (p=0.054 and 0.027 respectively).
Conclusions:	Vasodilator therapy appears safe in Eisenmenger patients. Taking into 
account associated risk, prostaglandin therapy may provide superior benefit as assessed 
through 6-minute walk, and may be the preferred vasodilators in these patients.
2:30 p.m.
1011-53	 Clinical	Course	and	Risk	Factors	for	Cardiac	Events	
After	the	Age	of	41	Years	in	Subjects	with	the	
Congenital	Long	QT	Syndrome
James Bradley, Ilan Goldenberg, Arthur J. Moss, Wojciech Zareba, Jennifer L. 
Robinson, Slava Polonsky, University of Rochester, Rochester, NY
Background: Data on the clinical course of patients affected with the congenital Long 
QT syndrome (LQTS) are limited mostly to the first 4 decades of life. The aim of this study 
is to determine and evaluate the risk factors for cardiac events (comprising syncope, 
aborted cardiac arrest or LQTS-related death) after the age of 41 years in LQTS subjects 
enrolled in the International LQTS Registry.
Methods: The clinical course after the age of 41 years in 540 LQTS subjects, defined by QTc 
and/or genetic criteria, was compared with 236 borderline, and 420 unaffected subjects.
Results: The rate of cardiac events after age 41 was significantly higher among affected 
LQTS subjects as compared with borderline and unaffected subjects (Figure). Risk factors 
for cardiac events among affected patients included: a history of syncope (HR=4.25; 
p<0.001), female sex (HR=1.85; p=0.01), QTC >550 msec (HR=2.10; p=0.01), a history 
of coronary artery disease (HR=4.08; p=0.03) and a history of asthma (HR=2.53; p=0.04). 
β-blocker therapy was associated with a significant reduction in the risk of cardiac events 
after age of 41 among affected subjects (HR=0.50; p=0.03).
Conclusions: LQTS subjects maintain a considerable risk of cardiac events after the 
age of 41 years with several age-specific risk factors. β-blocker therapy appears to be 
effective in this older age group. 
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1011-54	 Cardiac	Venous	Anatomy	in	Congenitally	Corrected	
Transposition	of	the	Great	Arteries	Provides	Delivery	
Options	for	Device-Related	Therapies
Natalie A. Bottega, William D. Edwards, Heidi M. Connolly, Samuel J. Asirvatham, Mayo 
Clinic, Rochester, MN
Background: Exact knowledge of the cardiac venous system is required for ICD, 
resynchronization and ablation therapies for complications of congenitally corrected transposition 
of the great arteries (CCTGA). Details of the venous drainage from the left ventricle (LV) and 
right ventricle (RV) with respect to delivering these therapies are unknown.
Methods: Hearts with CCTGA were identified from the pathology database at Mayo 
Clinic. Coronary sinus (CS) anatomy and the distances from the CS ostium to the major 
cardiac veins were evaluated. Thebesian veins (TV) with ostia >1 mm, epicardial veins 
and venous collaterals were quantified noting from which ventricle drainage originated.
Results:	There were 58 hearts with CCTGA. The CS was unidentifiable in 7 due to 
slicing. Six hearts had an abnormal CS with 2 displaced above the AV groove (2.3 and 
0.5 cm), 2 with atretic ostia and 2 with ostia posterior to the eustachian ridge. Further 
details of the cardiac veins were assessed in 40 hearts. There were 28 hearts with ≥1 TV 
with 1-4 mm ostia draining the LV into the right atrium (Figure 1). Venous collaterals from 
the RV were seen in 80%. The 12 hearts with unidentifiable TV had venous collaterals 
from the RV to the major cardiac veins. Epicardial veins extended to the proximal, middle, 
and distal thirds of the RV in 54%, 17% and 4% respectively.
Conclusion: The CS was normal in 88% of hearts with CCTGA. When CS abnormalities 
preclude venous access to the RV and LV, numerous large TV may be identified to deliver 
device-related therapy.
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1017-27	 Long-term	Follow-up	of	Stents	Placed	in	Infants	with	
Congenital	Heart	Disease
Robert Stanfill, David G. Nykanen, Sandra Osorio, Ruby Whalen, Evan M. Zahn, Miami 
Children’s Hospital, Miami, FL
Background:	Implantation of balloon expandable stents (BES) in infants has been shown 
to be technically feasible however there is limited long-term data available describing the 
fate of BES as these children grow.
Methods:	A retrospective analysis was performed on the earliest consecutive series of 
infants who underwent BES placement at our institution between 10/95-12/99.
Results:	Implantation of 33 BES was attempted in 27 infants (median age = 10(.25-24) 
mos, wt = 8.1(3.4-14.5) kg). BES used were: 16 large (max diameter 18 mm), 13 medium 
(max diameter 10 mm), and 4 coronary (max diameter 4 mm). Implant success was 
achieved in 31/33 (94%). There were 3 non-procedure related deaths within 30 days 
of implantation, 1 pt was lost to follow-up and 1 had acute thrombosis of the BES. The 
remaining 22 pts (26 BES) form the study group. A total of 44 re-catheterizations were 
performed during follow-up. Nineteen stents in 17 pts underwent 32 re-dilations with no 
procedural complications or deaths. Latest re-catheterization (52 ±31 mos post-implant) 
in pts who underwent re-dilation demonstrated an increase in BES diameter of 24%±31 
since initial implant. There were no instances of late BES migration, thrombosis, fracture 
or occlusion. Seven BES (1 large, 4 medium, 2 coronary) were electively removed or 
ligated at the time of planned surgery: 5 pulmonary artery or conduit stents were removed 
during conduit replacement, 1 PDA BES and 1 shunt BES were ligated during definitive 
surgical repair. No complications occurred secondary to surgical manipulation of stents. 
All remaining in situ BES (18/18) are patent with no significant obstruction an average of 
101±11.4 mos post-implant. At latest clinical follow-up 21/22 pts are alive and well. There 
has been one late unrelated death 51 mos after implantation.
Conclusions:	BES implantation in infants is safe and effective. Over time, these devices 
can be enlarged through serial re-dilation to keep pace with somatic growth. Efforts 
should be made to implant stents with adult diameter potential in children who will not 
require further cardiac surgery. In pts who will require future surgery, smaller stents can 
be used effectively and removed or ligated safely at a later date if needed.
10:00 a.m.
1017-28	 Novel	NKX2.5	Mutations	In	Sporadic	Cardiac	Septal	Defects
Sreekanthan Sundararaghavan, Neeraj Tatipalli, Center for Liver research &Diagnostics, 
Hyderabd, India, Apollo Hospitals, Hyderabad, India
Homeodomain (HD) protein in NKX2.5 is an evolutionary conserved transcriptional factor 
required for cardiac development. Familial mutations in the HD of NKX2.5 gene are associated 
with cardiac abnormalities, but mutations are rare in sporadic cases. Mutations in isolated 
Ventricular Septal Defects (VSD), Atrial Septal Defects (ASD) have not been studied in detail.
Materials & Methods: 47 consecutive patients with septal defects willing to provide blood 
sample were analyzed. Patients with syndromic features, associated cardiac defects 
primarily conotruncal malformations were excluded. Patients were screened for NKX2.5 
HD alterations by nested PCR and sequencing.
Results: 4 heterozygous mutations (Arg197Gly, Arg197Asn, Arg197Thr, & Gln196Leu) 
predicted to alter the encoded protein in helix 3 of HD were identified in 19 of 47 patients 
(41%). 55% (15 out of 27) of perimembranous VSDs had mutations in the NKX2.5 HD helix 
3. However none of the 9 isolated ASD patients showed any mutations in NKX2.5 HD.
The 4 mutations identified in the cohorts were not present in 38 controls, sequenced for 
2nd exon of NKX2.5 open reading frame.
Conclusion: 1. All mutations altered highly conserved amino acids in helix 3 of HD, which 
are involved in binding of NKX2.5 to target DNA resulting in haploinsufficiency.
2. Majority of patients with VSDs had mutations in the 197th
amino acid while isolated ASDs seldom showed mutations in the HD of NKX2.5.
10:00 a.m.
1017-29	 Early	Experience	of	Cryoablation	for	Accessory	
Pathways	in	Children
Grace L. Smith, John M. Clark, Akron Children’s Hospital, Akron, OH
Background and Objectives: Cryoablation is the preferred treatment of supraventricular 
tachycardia due to atrioventricular nodal reentry in children. However, experience with 
cryoablation for accessory pathway mediated tachycardia is limited. We report our 
institutional results of children undergoing this procedure.
Methods: From 1/6/2005 to 8/31/2006 thirty-one patients with accessory pathway 
mediated tachycardia underwent cryoablation in our institution. Ages range from 6-19 
years. Sixteen patients had manifest preexcitation and 18 had concealed accessory 
pathways. Three patients each had two accessory pathways for a total of 34 accessory 
pathways in this study. There were 18 left sided pathways, 6 septal pathways, and 10 right-
sided pathways. A 4 mm-tip or 6 mm-tip cryocatheter was used with three-dimensional 
mapping or fluoroscopic guidance.
Results: Thirty out of thirty-four accessory pathways (88%) were successfully cryoablated. 
Three patients with unsuccessful cryoablation had successful RF ablation in the same 
procedure, yielding an overall success of 97%. There were no procedural complications. 
Average procedure time was 3.64 hours, fluoroscopy time 11.4 minutes. In follow-up 
ranging from 7 to 560 days, there has been two late recurrence of WPW (6%).
Conclusions: Our early experience with cryoablation of accessory pathways in children 
shows satisfactory acute success rates, similar to radiofrequency ablation. There was 
no increase in procedural time nor recurrence rate as has been previously reported. 
Cryoablation is safer than radiofrequency and is now our method of choice for ablation of 
all reentrant supraventricular tachycardias.
10:00 a.m.
1017-30	 Early	Left	Ventricular	Dysfunction	is	Associated	with	
Coronary	Artery	Dilation	in	Kawasaki	Disease
Beth F. Printz, Lynn A. Sleeper, Jane W. Newburger, L. LuAnn Minich, Timothy Bradley, 
Meryl S. Cohen, Deborah Frank, J. Rene Herlong, Renee Margossian, Girish Shirali, 
Masato Takahashi, Steven D. Colan, for the Pediatric Heart Network Investigators, 
Columbia University Medical Center, New York, NY, Children’s Hospital Boston, Boston, MA
Background:	 Coronary artery (CA) dilation, left ventricular (LV) dysfunction, mitral 
regurgitation (MR), and aortic root dilation are recognized complications of Kawasaki 
Disease (KD), but their interrelationships have not been well described.
Methods:	 The NHLBI-sponsored Pediatric Heart Network multi-center, prospective, 
randomized trial of pulse steroids in primary treatment of KD included centrally interpreted 
echocardiograms that were performed on ≥195 of the 199 subjects at the time of KD 
diagnosis (dx) and at 1 and 5 weeks post-dx. We combined the two treatment arms 
because their echocardiographic outcomes were not different. LV dimensions and aortic 
root size (at the sinus of Valsalva) were assessed using BSA-adjusted Z scores for a 
normal population. We defined LV dysfunction as an age-adjusted LV shortening fraction 
Z score < -2, and CA dilation if the subject’s BSA-adjusted CA Z score was > 2 in either 
the proximal left anterior descending or right CA.
Results:	Mean age at KD dx was 3.3±2 years (16% <1 year); 37% were male. At dx, LV 
dysfunction was present in 20% and was associated (P = .001) with baseline CA dilation, 
present in 29%. Subjects with LV dysfunction at dx, compared to those with normal LV 
function, also had greater odds of CA dilation at 1 and 5 weeks post-dx (5 week odds 
ratio 2.7, 95% CI 1.2-6.3). At dx, LV end-diastolic dimension, end-systolic dimension, and 
aortic root size were each significantly greater than normal; at least mild MR was present 
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in 27% of subjects; and each was associated with greater CA size. Subjects with MR 
were more likely to have LV dysfunction (p=.0004) and increased LV diastolic dimension 
(p=.02) at dx but not at 5 weeks. LV function had recovered completely by 1 week, and LV 
parameters at 1 and 5 weeks post-dx were not associated with CA size. Aortic root and 
CA size were significantly greater than normal and correlated with each other at 1 and 5 
week (p=.006) follow-up.
Conclusion:	Early LV dysfunction is associated with CA dilation in the first 5 weeks after 
KD dx. MR and aortic root dilation are also common at dx and are associated with CA 
dilation. The inter-relation of echocardiographic abnormalities in acute KD suggests that 
they share a common etiologic mechanism. 
10:00 a.m.
1017-31	 Left	Ventricular	Dysfunction	is	Associated	with	Intra-
ventricular	Dyssynchrony	in	Children
G. Hamilton Baker, Anthony M. Hlavacek, Karen Chessa, Dawn Fleming, Pamela Ruff, 
Girish Shirali, Medical University of South Carolina, Charleston, SC
Introduction: The incidence of left ventricular (LV) dyssynchrony in children with LV 
dysfunction is not well studied. We utilized three-dimensional echocardiography (3DE) to 
identify and quantify LV dyssynchrony in children with LV dysfunction, compared to body 
surface area (BSA) matched controls.
Methods: From 5/05 - 5/06, 3DE LV full volumes were acquired in 18 children, 9 with 
LV dysfunction (2D fractional shortening < 28%); (median age	14.1 yr (4.9 - 18.6)); and 
9 BSA-matched controls (median age 12.5 yr (4.5 - 16.2)). For the analysis, the LV was 
subdivided using a 17 segment model. Three indices of dyssynchrony, previously used 
in adults to quantify temporal dispersion of regional LV contraction were calculated. 
For the first index, the time from end-diastole to the minimal systolic volume for 16 LV 
segments (apex excluded) was calculated. To control for heart rate, these times were 
then expressed as a percent of the R-R interval. The standard deviation of these times 
was used as a 16 segment dyssynchrony index (16-SDI). The second index (12-SDI) 
was similarly calculated using 6 basal and 6 mid segments. The third index consisted of 
6 basal segments (6-SDI). Results were analyzed using Wilcoxon rank-sum tests and 
Spearman correlation coefficients.
Results: Compared to controls, the dysfunction group exhibited significantly increased 
16-SDI and 12-SDI; the increase in 6-SDI approached statistical significance. The median 
16-SDI was 4.37% (2.29-14.77%) in the dysfunction group and 2.1% (0.71 - 2.78%) in 
controls (p= 0.008). The median 12-SDI was 2.82% (0.99 - 12.26%) in the dysfunction 
group and 1.15% (0.77 - 2.23%) in controls (p=0.01). The median 6-SDI was 1.97% (0.97 
- 12.52%) in the dysfunction group and 1.28% (0.53 - 2.33%) in controls (p = 0.08). The 
16-SDI was negatively correlated with 3D LV ejection fraction (r = -0.81, p < 0.001) and 
2D fractional shortening (r = - 0.61, p = 0.01).
Conclusions: Children with LV dysfunction demonstrate increased dyssynchrony by 3DE, in 
a pattern that is negatively correlated with 3D ejection fraction and 2D fractional shortening. 16-
SDI was a more robust indicator of dyssynchrony than indices containing fewer segments.
10:00 a.m.
1017-32	 Impact	of	Stent	Implantation	on	Pulmonary	Artery	Growth
Cheryl M. Takao, Rabih K. Hamzeh, Dana Connolly, Frank F. Ing, Rady Childrens 
Hospital of San Diego, San Diego, CA
Background: Pulmonary artery (PA) growth in infancy is dependent on flow, but there is 
little data on vascular growth after stent implantation (SI) for PA stenosis. The purpose of 
this study was to evaluate the impact of SI on PA growth.
Methods: Pts who underwent unilateral SI from 1998-2005 were included. Pts with 
interventions on the contralateral (C) PA were excluded. The C PA served as a control for 
normal growth over time. Pts were separated into single ventricle (SV) & two-ventricle (2V) 
groups. Data analyzed included lobar & main branch diameters (D) pre-stent & at f/u cath.
Results: 87 pts underwent unilateral PA SI & 39 met inclusion criteria. For the SV 
group(18), mean age & wt were 3.5yrs(4.6mo-32yrs) & 13.8kg(4-86). Stented PA 
D ↑118% (3.9 ± 2.4 to 8.5 ± 2.9mm) & the C PA measured 8.7 ± 3.4mm. At f/u cath 
(14±9.6mo), the stented PA ↓14% (7.3 ± 3.1mm) & the C PA ↑10% (9.6 ± 3mm). The 
upper & lower lobes on the stented PA ↑ 0% (2.9 ± 1.6 to 2.9 ± 1.7mm) & 3% (6.8 ± 2.7 
to 7.0 ± 2.5mm) respectively. On the C PA, the upper & lower lobes ↑ 5%(4.2 ± 1.2 to 
4.4 ± 1.3mm) & 9%(7.8 ± 2.9 to 8.5 ± 3.0mm) respectively. For the 2V group(21), the 
mean age & wt were 4.8yrs(4.5mo-17yrs) & 16.4kg(5.4-56). The stented PA D ↑100% 
(4.5 ± 2.2 to 9.2±2.4mm) & the C PA measured 10.8 ± 3.7mm. At f/u (20±13.5mo), the 
stented PA ↓10% (8.3 ± 2.8mm) & the C PA ↑13% (12.2 ± 3.8mm). On the stented PA, 
the upper & lower lobes ↑ 19% (3.7 ± 2.0 to 4.4 ± 2.0mm) & 14% (7.7 ± 2.3 to 8.8 ± 
2.2mm) respectively. On the C PA, the upper & lower lobes ↑ 18% (5.0 ± 1.9 to 5.9 ± 
2.2mm) & 15% (9.9 ± 3.3 to 11.4 ± 3.2mm) respectively. Despite lack of growth of the 
stented main branch, there was no statistically significant difference in growth at the lobar 
level between the stented & unstented sides in either group. These data suggest that the 
lobar branches of the stented PA “kept up” with normal growth when compared to the 
C unstented PA. There was significantly greater growth of all lobar branches in 2V pts 
compared to SV pts(p=0.001). 
Conclusion: SI for PA stenosis appears to be effective in promoting normal lobar growth in both 
SV and 2V pts. Overall, lobar branch growth is greater in 2V pts compared to SV pts. Long term 
f/u is needed however these data suggest early & aggressive PA stenting is beneficial.
10:00 a.m.
1017-33	 Acute	Changes	in	Exercise	Performance	after	Relief	of	
Unfavourable	Right	Ventricular	Loading	Condition
Philipp Lurz, Johannes Nordmeyer, Louise Coats, Sachin Khambadkone, Dolf 
Odendaal, Bryan Mist, Andrew Taylor, Philipp Bonhoeffer, Graham Derrick, Great 
Ormond Street Hospital for Children, London, United Kingdom
Background:	  We showed that left ventricular stroke volume (LVSV) is improved after 
percutaneous pulmonary valve implantation (PPVI) for relief of right ventricular (RV) 
volume or pressure overload. In this study, we sought to determine whether these changes 
are reflected in the parameters of maximal and submaximal exercise performance.
Methods: Cardiopulmonary exercise testing was performed prior to and after PPVI in 
93 patients, divided into 2 groups: Group 1 - predominately pulmonary stenosis (echo 
gradient >50mmHg); Group 2 - predominately pulmonary regurgitation (>20% on MR). 
Patients who met both criteria were excluded.
Peak VO2, workload, VE/VCO2 and work-efficiency were determined. LVSV was 
assessed by magnetic resonance.
Results: After PPVI, patients with stenosis showed a significant improvement in peak 
VO2 and submaximal exercise parameters. There was no significant change in peak 
VO2 in the regurgitant group, though the increase in LVSV in this group was related to an 
improvement in submaximal exercise indices and maximal workload.
Conclusion: Relief of pulmonary stenosis leads to an acute improvement in maximal and 
submaximal exercise capacity. In the context of pulmonary regurgitation, a demonstrated 
increase in LVSV is not associated with increased peak VO2. Interestingly, workload 
and submaximal exercise indices, which better reflect patients everyday exercise 
requirements, are significantly improved after relief of RV volume overload. 
stenotic	group	(n=36) regurgitant	group	(n=34)
Pre Post t-test Pre Post t-test
LV	SV	(ml/m2) 43,3±10,5 46,5±9,7 p=0.016 41,4±13,7 46,8±10,1 p<0.001
Peak	VO2	(ml/kg/min) 24,9±6,1 27,7±6,3 p=0.002 23,6±7,2 24,6±6,5 p=0,33
Workload	(watts) 123,9± 39,27 136,4± 41,49 p=0.08 94,6±35,2 100,8±39,29 p=0.01
VE/VCO2	slope 33,3±5,5 31,6±4,7 p=0.01 32,1±6,6 30,1±6,3 p=0.01
Work	efficiency	slope 9,47±1,64 9,75±2,19 p=0.69 9,33±1,7 9,76±2,06 p=0.51
10:00 a.m.
1017-48	 Functional	Tissue	Engineered	Vascular	Grafts	Guide	
Remodeling	Processes	In	Vivo
Jens M. Kelm, Doerthe Schmidt, Fred Schoen, David Fluri, Gregor Zuend, Simon P. 
Hoerstrup, University Hospital Zuerich, Zuerich, Switzerland
Background: Currently, prosthetic substitutes still represent the state-of-the-art for the 
revascularization of ischemic cardiac tissue and the repair of congenital malformation. 
De novo generation of tissue engineered vascular grafts seeks to reduce the restriction 
of artificial grafts and in a long-term large animal study, we have recently shown that 
autologous-derived tissue engineered cardiovascular arterial grafts are an attractive 
alternative with functional growths potential. Nevertheless, so far the cell fate during the 
neo-tissue formation in vivo remains elusive, particular with respect to cell senescence 
after in vitro expansion.
Methods: To analyze the cellular remodeling processes tissue engineered construct-
derived myofibroblasts as well as native pulmonary artery-derived myofibroblasts were 
isolated after 20 (n=3) and 100 weeks (n=3).
Results: Phenotypic characterization by FACS analysis displayed similar expression 
profiles of α-SMA, vimentin and desmin of tissue engineered construct-derived 
myofibroblasts and their native counterparts after 20 weeks and after 100 weeks 
in vivo, respectively. Telomere length determination by flow fish analysis using FITC-
labeled peptide nucleic acid (PNA) probes targeted against the repetitive sequence 
TTAGGG demonstrated significant differences in the relative telomere length (RTL) 
after cell expansion, prior seeding by a decrease of 50% in the RTL (n=6). In contrast, 
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no significant differences in the telomere length of tissue engineered construct-derived 
myofibroblasts and their native counterparts could be detected. Histological analysis of 
the tissues engineered constructs demonstrated cellular migration from bordering native 
pulmonary artery with displaying remodeling and cell replacement.
Conclusions: These results indicate cellular in-growth of native myofibroblasts into the 
tissue engineered conduit after implantation of the tissue engineered vascular grafts, 
replacing the in vitro expanded cells. Thus, the engineered tissues serve as a biological 
matrix for their native counterparts and guide in vivo remodeling and regeneration 
processes on a cellular level.
10:00 a.m.
1017-49	 Discrete	Subaortic	Membrane:	Echo	Does	not	Reliably	
Predict	Aortic	Valve	Impingement
David L.S. Morales, Justin H. Booth, Susan C. Powers, Shuping Ge, E. Dean McKenzie, 
Jeffrey S. Heinle, Charles D. Fraser, Jr., Baylor College of Medicine, Houston, TX, Texas 
Children’s Hospital, Houston, TX
Background: Increasing left ventricular outflow tract obstruction (LVOTO) is a well-
accepted indication for resection of a discrete subaortic membrane (DSM). However, this 
indication overlooks a DSM’s progressive nature to grow and encroach onto the leaflets 
of the aortic valve (AV), potentially impairing future AV function. While echocardiography 
(echo) is used to follow the progression of LVOTO, its ability to demonstrate the extent 
of DSM advancement onto the AV is unclear. Therefore, if echo cannot determine AV 
involvement except for the late finding of aortic insufficiency, perhaps resection upon 
diagnosis is warranted. Herein, the ability of echo to determine DSM encroachment on 
the AV is analyzed.
Methods: Between 10/1995 - 5/2006, 48 consecutive patients underwent primary 
resection for isolated DSM at Texas Children’s Hospital. Mean age: 7.2 ± 6.0 years; 
Mean BSA 1.9 ± 0.4 m2. Concomitant procedures: atrial septal defect closure (7). Data 
on whether the DSM involved the AV on transthoracic echo was collected from the 
official preoperative reading and from a retrospective blinded review of the echos by an 
independent echocardiographer. Both were compared to the intraoperative findings.
Results: There were no early or late deaths. There were no strokes, re-operations for 
bleeding, or need for a pacemaker. The mean hospital length of stay was 4.5 ±1.8d. 
Mean follow-up was 3.4 ± 2.9 years. 4 patients (8%) required re-resection of the DSM. 
The preoperative and the blinded readings both predicted a statistically lower rate of 
AV involvement (23% {11/31} & 21% {10/31}, respectively) than found at surgery 
(65% {31/48}) [p < 0.01]. The sensitivity and specificity of pre-op echo to diagnose AV 
involvement is 35% and 70%.
Conclusions: Since echo is not sensitive in assessing whether a DSM involves the AV 
and primary DSM resection has minimal to no morbidity or mortality, resection may be 
indicated at diagnosis to avoid or minimize future AV impairment.
10:00 a.m.
1017-51	 Cachexia	as	a	Predictor	of	Mortality	Among	an	Outpatient	
Population	of	Adults	With	Congenital	Heart	Disease
Isabelle F. Vonder Muhll, Kostas Dimopoulos, Richard A. Lawrance, Aude Cholet, Katya 
Stehr, Michael Gatzoulis, Royal Brompton Hospital, London, United Kingdom, University 
of Alberta Hospital, Edmonton, Canada
Background: Cardiac cachexia has long been recognised in end-stage cardiac disease, 
but has not been greatly studied in adult congenital heart disease (ACHD). We sought to 
determine the prevalence and predictors of wasting in this patient population and whether 
the cachectic state is a prognostic marker for mortality in this patient group.
Methods: Between August 2002 and April 2003, we studied 438 consecutive outpatients 
(age 36 +/-13 years, 50% female) with ACHD. We assessed body mass index (BMI), 
frame size and percentage body fat, and these were used prospectively to identify 
patients with cachexia, defined as having a BMI<20 plus evidence of body wasting, either 
with low body fat or being <85% of predicted ideal body weight.
Results: 11.6% (45% female) of outpatients studied met the criteria for cachexia (BMI 
17.6+/-1.4kg/m2, percent body fat 12+/-7%, percent predicted ideal body weight 82+/-6%). 
Independent clinical predictors / associates of cachexia in ACHD included younger age, 
lower blood pressure, cyanosis and complex congenital cardiac diagnoses. By the end of 
follow up in March 2006, 25 patients (5.7%) had died (after a mean of 407+/-312 days). 
Percentage body fat, percentage predicted ideal body weight and the cachectic state were 
univariate predictors of mortality, with cachexia remaining independent of age, heart rate 
and oxygen saturation in multivariate logistic regression analysis. A risk model to predict 3-
year mortality derived from these three variables as well as the cachectic status yielded an 
area under the receiver operating characteristics curve of 0.81 (0.72-0.91).
Conclusions: Cachexia is present in a significant proportion of ACHD patients. Our 
data suggests that complex congenital heart disease and cyanosis are associated with a 
cachectic body habitus, and that the presence of cachexia is predictive of mortality in ACHD. 
Routine assessment of cachexia in the ACHD patient may help identify a subset of patients 
at increased risk of mortality, and who may benefit from more intensive intervention.
10:00 a.m.
1017-52	 The	Interventricular	Relationship	In	Eisenmenger	
Syndrome:	Findings	With	Cardiac	Magnetic	Resonance	
And	Late	Gadolinium	Enhancement.
Craig S. Broberg, Sanjay Prasad, Michael A. Gatzoulis, Oregon Health and Science 
University, Portland, OR, Royal Brompton Hospital, Imperial College London, London, 
United Kingdom
Background: A relationship between ventricular volume and myocardial fibrosis has 
been demonstrated in the pressure loaded right ventricle in congenital defects using 
cardiovascular magnetic resonance (CMR), but never in Eisenmenger syndrome, and 
the significance of fibrosis is uncertain in this group.
Methods: Eisenmenger patients (N=48) underwent CMR (1.5 T Siemens Sonata) to 
quantify right and left ventricular (RV and LV) volume and fibrosis by late gadolinium 
enhancement (LGE). Same-day measurement of oxygen saturation, hemoglobin, and 
exercise capacity was performed.
Results: The RV and LV were structurally and functionally similar. All patients had severe 
RV hypertrophy (RV mass 65±24 g/m2 vs. 68±24 g/m2 for LV). There was a strong 
correlation between RV and LV ejection fraction (r=0.74, p<0.001). LGE was tested in 28 
patients, and positive in 18 (64%), most often in small areas of RV subendocardium (50%), 
but also within trabeculae (36%), papillary muscles (29%), and RV-LV junction (25%). 
Those with LGE+ were not different in age, shunt size/type, RV or LV mass, volume, 
ejection fraction, pulmonic/systemic flow ratio, nor in oxygen saturation, hemoglobin, 
ANP, BNP, history of arrhythmia or exercise capacity compared to those without LGE.
Conclusions: In Eisenmenger syndrome there is a strong interventricular relationship 
and dysfunction progresses in both ventricles. Fibrosis by LGE is common but does not 
correlate with ventricular size, function, degree of cyanosis, or exercise	capacity. 
10:00 a.m.
1017-53	 Left	Ventricular	Remodeling	and	Systolic	Function	After	
Closure	of	Patent	Ductus	Arteriosus	in	Adults:	Device	
and	Surgical	Closure
Young-Hoon Jeong, Tae-Jin Yun, Jong-Min Song, Jung-Jun Park, Dong-Man Seo, Jae-
Kon Koh, Duk-Hyun Kang, Jae-Kwan Song, Asan Medical Center, Seoul, South Korea
Background: Left ventricular remodeling after patent ductus arteriosus (PDA) closure 
and predictors of left ventricular systolic function late after the closure remain to be clearly 
demonstrated.
Methods: In 72 patients with PDA including 35 patients who received successful 
occlusion using Amplatzer device (AD group) and 37 who received surgical closure (OP 
group), echocardiographic parameters were measured before closure, 1 day (AD group) 
or within 7 days (OP group) after closure, and then followed up for 21±26 months.
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Results: Left ventricular ejection fraction (EF) and end-diastolic volume index (EDVI) were 
significantly decreased immediate after closure, while end-systolic volume index (ESVI) did 
not (Figure). Post-closure deterioration of EF in AD group was smaller than that in OP group 
(-7±7 vs. -18±10%, p<0.001). After long-term follow-up, ESVI decreased significantly, but 
EF remained low compared to pre-closure state in both groups. Follow-up EF negatively 
correlated with ESVI (r=-0.62) and EDVI (r=-0.33), and positively with EF (r=0.63) of pre-
closure state. Pre-closure EF was the only independent determinant of follow-up EF by 
multiple stepwise linear regression analysis (p<0.001). Pre-closure EF ≥ 62 % predicted 
follow-up normal EF (≥ 50%) with a sensitivity of 70 % and a specificity of 80 %.
Conclusion: Left ventricular EDVI decreases early and ESVI decreases late after PDA 
closure. Left ventricular EF before closure is the best index to predict late post-closure EF. 
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1023-27	 Warfarin	Treatment	In	Patients	With	Giant	Coronary	
Aneurysms	Caused	By	Kawasaki	Disease
Kenji Suda, Yoshiyuki Kudo, Masahiko Matsumura, Takashi Higaki, Yuichi Nomura, 
Masaru Miura, Mamoru Ayusawa, Shunichi Ogawa, Toyojiro Matsuishi, Kurume 
University, Kurume, Japan, Tenri Hospital, Tenri, Japan
Purpose: To determine the effectiveness and risk of oral warfarin treatment in patients 
with giant coronary aneurysms (GA) caused by Kawasaki disease (KD).
Methods: A multi-institutional cohort study was conducted. Eighty one (64 male and 17 
female) patients with GA > 8 mm in diameter and had been treated for > 3 months with 
warfarin were enrolled. The diameter of GA was median of 11.0 (8-39.5) mm. The age at 
KD was median of 2.7 (0.2 - 14.5) years old. Warfarin was started from 0 (0 - 17) months 
after the onset of KD and had been prescribed for 4.2 (0.2 - 22.5) years giving 466.9 of 
patient-year. Target international normalized ratio of prothrombin time was 1.5 in 5, 1.5 
- 2.0 in 29, 2.0 in 27, 2.0-2.5 in 11, >2.5 in 3 and unknown in 6 patients.
Results: During this observational period, 4 patients suffered from acute myocardial 
infarction (AMI). Among these 4, 1 patient suffered from 2 events of AMI and 1 course 
of intracoronary thrombolysis (ICT) but died, 1 patient experienced 4 events of AMI and 
4 courses of ICT and alive, 1 underwent 1 course of ICT and balloon angioplasty and 
alive, and the other 1 recovered only with medical treatment. Visualization of coronary 
thrombus enforced ICT in 3 patients (1 to 4 times). Calculated acute coronary event rate 
was 1.5 per 100 patient-year. Excluding 7 patients who had acute coronary event prior to 
warfarin treatment, freedom of acute coronary event was 99 % at 1 month and 97 % at 
10 years. Of note, within 6 months after discontinuation of warfarin, 2 patients suffered 
from AMI and 1 of them died. Catheter and surgical intervention was offered in 27 patients 
for the development of coronary stenosis. In 67 patients with sufficient data available, 8 
hemorrhagic episodes were observed in 5 patients giving 2.2 episodes per 100 patient-
year. Of them 4 were caused by blunt hit and 1 was acute subdural hematoma that 
required emergency operation.
Conclusions: Warfarin treatment is effective to prevent acute coronary event in most 
patients with GA caused by KD though it has some risk of hemorrhagic complications. 
In conjunction with warfarin treatment, regular check up of coronary anatomy and 
appropriate coronary interventions must be offered.
2:30 p.m.
1023-28	 Multidetector	Computed	Tomograpic	Angiography	
Results	in	a	Lower	Radiation	Dose	than	Diagnostic	
Catheterization	in	Pediatric	Patients
Anthony M. Hlavacek, Denise M. Mulvihill, Javier G. Gonzalez, Girish S. Shirali, Donald 
G. Frey, Medical University of South Carolina, Charleston, SC
Background: Advances in mutidetector computed tomography have allowed CT angiography 
(CTA) to become a useful imaging modality in patients with congenital heart disease. Yet, 
exposure to ionizing radiation is not without risk. This study aims to quantify the radiation dose 
of CTA in comparison to diagnostic catheterization (DC) in pediatric patients.
Methods: Three tissue equivalent anthropomorphic phantoms of differing sizes 
(neonate, 1 yo, and 5yo) were employed to determine the radiation dose of DC and 
CTA (64-slice). In order to simulate a standard DC, the logs from our catheterization 
laboratory over a 2 month period were reviewed for the median fluoroscopy time and 
number of cineangiograms. Each phantom was exposed to 1 minute of fluoroscopy 
and 1 cineangiogram. The dose was calculated accordingly. Non-gated CTA, as is our 
standard practice, was performed on each phantom. An additional cardiac-gated scan 
was performed on the 5 year-old phantom for comparison.
Results: The median fluoroscopy time was 16 minutes (range 5.1-73.8 min) and the 
median number of cineangiograms was 2 (range 1-12). 
Size of phantom Dosetype
DC
(mGy)
Non-gated CTA
(mGy)
Gated CTA
(mGy)
Neonate
Central 81 1.2
Peak surface 165 1.2
1 year-old
Central 112 1.6
Peak surface 248 1.8
5 year-old
Central 96 2.5 21.6
Peak Surface 411 3.2 26.3
Conclusion: CTA in pediatric patients results in a considerably smaller radiation dose 
than DC. Non-gated CTA results in a dose similar to the average yearly background 
radiation dose from natural sources (1.5-3mGy). Cardiac gating results in approximately 
an 8-fold increase in dose. Therefore, gating should only be used when necessary to 
evaluate coronary arteries, intracardiac anatomy, or for volumetric analysis.
2:30 p.m.
1023-29	 Aspirin	And	Coumadin	Are	Safe	And	Effective	
Therapies	After	The	Fontan	Operation
Michelle M. Steltzer, Michael G. Earing, Nancy A. Rudd, Kathleen A. Mussatto, Joan Gill, 
Peter C. Frommelt, Medical College of Wisconsin, Milwaukee, WI, Children’s Hospital of 
Wisconsin, Milwaukee, WI
Background:	Use and maintenance of chronic oral anticoagulation (AC) after the completion 
Fontan operation remains controversial. In 2000, a standardized advanced practice protocol 
was developed that included low dose Aspirin (ASA) ranging 3-5mg/kg/day dose and low 
dose Coumadin with a target INR 1.5-2.0. This protocol is initiated as an inpatient.
Methods:	A retrospective chart review of 138 consecutive pts who underwent Fontan 
palliation from 1/2000 through 11/2005.
Results:	The predominant anatomic diagnoses for the group were hypoplastic left heart 
syndrome (41%) and tricuspid atresia (27%), and mean age at surgery was 38.6 ± 29.8 
months. The majority had an extracardiac conduit (79%) versus a lateral intracardiac 
tunnel (21%). Median length of hospital stay was 8 days (range 5-64). There were 5 
(3.6%) early deaths, 1 late death and 1 patient that underwent transplant at 4.5 years 
post-Fontan. One hundred and seven patients (81%) were discharged on the protocol. 
Follow-up data was available on 96 patients with a mean duration of 37.9 ± 21.4 months. 
Coumadin dosing averaged 0.1 mg/kg/day and INR at discharge was 1.9 ± 0.9. Mean 
frequency of outpatient (OP) phlebotomy for coumadin monitoring was once every 3 
months, and bleeding complications were (6%) with 2 pulmonary hemorrhages, 2 GI 
bleeds, and 2 orbital hematomas. Thromboembolic (TE) complications were identified in 
14 pts (15%) and were more likely to occur in those patients not on protocol (24% versus 
7%; p<0.05). There was no correlation between anatomic diagnosis, type of Fontan, or 
use of ASA, and TE frequency. The majority of the TE were diagnosed during the Fontan 
hospitalization (10/14). Of the 4 OP TE events, 2 occurred during interventional cardiac 
catheterization; the other 2 were in patients not on protocol.
Conclusions: The use of ASA and Coumadin after Fontan appears safe and can be 
monitored without frequent phlebotomy. Fontan patients are at significant risk of TE 
events, particularly early post-op and during interventional procedures. The AC protocol 
described here appears to favorably impact the occurrence of TE at intermediate follow-
up and has become our standard of care.
2:30 p.m.
1023-30	 Cytomegalovirus	Replication	is	Associated	With	Endothelial	
Dysfunction	in	Pediatric	Heart	Transplant	Recipients
Jacob D. Simmonds, Matthew J. Fenton, Michael Burch, Nigel J. Klein, Elizabeth 
A. Ellins, Clare Storry, Shamus O’Meagher, Elizabeth M. Redmond, Ann E. Donald, 
Catherine A. Scott, Julian PJ Halcox, Great Ormond Street Hospital, London, United 
Kingdom, Institute of Child Health, University College London, London, United Kingdom
Background: Cytomegalovirus (CMV) can infect endothelial cells. CMV infection is 
associated with coronary arterial endothelial dysfunction in heart transplant patients and 
increases risk for post-transplant coronary vasculopathy, particularly in children. It is 
unknown whether CMV impairs systemic arterial endothelial function in these patients.
Methods: We studied 50 pediatric heart transplant recipients (aged 8 to 17 years, 27 
male), separated into two groups: Group 1 (n=12, 8 male) - patients with evidence of 
CMV replication post-transplant (positive CMV polymerase chain reaction [PCR] and/or 
seroconversion from negative to positive CMV IgG antibody), and Group 2 (n=38, 19 
male) - those without evidence of viral replication (negative PCR and no change in CMV 
IgG). Brachial artery endothelial function was assessed by high-resolution ultrasound to 
determine flow mediated dilatation (FMD), expressed as maximal percentage change in 
arterial diameter after reactive hyperaemia. Dilatation of the brachial artery to sublingual 
GTN (25μg) was used to assess endothelium independent dilatation.
Results: FMD was significantly worse in Group 1 than Group 2 (6.64 +/- 1.12% vs. 9.48 
+/- 0.79% respectively (mean +/- S.E.); p<0.02). This observed difference remained 
(p<0.02) after adjusting for age, sex, time since transplantation, and baseline arterial 
diameter. The response to GTN was similar in both groups. Neither donor/recipient CMV 
status pre-transplantation nor donor-recipient CMV mismatch was associated with FMD.
Conclusions: CMV infection is associated with impaired peripheral arterial endothelial 
function in heart transplant patients. Of note, evidence of active viral replication post-
transplantation appears more relevant than pre-transplantation CMV antibody status of 
donor or recipient. Further studies are needed to determine whether these findings are 
associated with the clinical extent and progression of graft vasculopathy.
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2:30 p.m.
1023-31	 A	Study	in	Ventricular-Ventricular	Interaction:	Left	
Ventricular	Diastolic	Biomechanics	and	Exercise	
Tolerance	in	Tetralogy	of	Fallot	Utilizing	Cardiac	
Magnetic	Resonance	Tagging
Mark A. Fogel, Mikael Concepcion, Stephen Paridon, Elizabeth Goldmuntz, Matthew 
Harris, The Childrens Hospital of Philadelphia, Philadelphia, PA, The University of PA 
School of Medicine, Philadlephia, PA
Background: Pts with repaired tetralogy of Fallot (TOF) have decreased exercise and 
left ventricular (LV) function.
Purpose/Methods: To determine LV regional diastolic biomechanics and its relationship 
to exercise, we used cardiac magnetic resonance & exercise tests to study 21 pts 
(14.8+5.6 years) divided into 2 groups: pulmonary regurgitant fraction < 20% (RF<20) 
(N=6) & > 20% (RF>20) (N=15). LV short axis was divided into 3 slice levels and 4 wall 
regions within a slice level.
Results: Strain. Diastolic strain in the superior, septal and inferiors walls correlated with 
forced expiratory volume-1st second (FEV1) (r=.51-.59, P<.001) in RF<20. Wall regions did 
not differ in diastolic strain in RF<20, however, it was more heterogeneous in RF>20 (7/12 
regions differ) with superior and posterior walls demonstrating the largest strains (graph).
Twist. Apical wall regions untwisted the most as compared to other short axis levels 
(P<.05). The superior wall demonstrated clockwise rotation whereas the inferior wall 
untwisted counterclockwise. Differences in direction of rotation existed between basal 
and apical slices for a given wall region. Positive correlations existed with ventricular 
performance and the basal superior wall in RF > 20 (r > 0.65, P < 0.03).
Conclusion: Regional diastolic relaxation correlates with FEV1 in RF<20 and is more 
homogeneous than in RF>20. Untwisting appears most vigorous at the apex with both + 
and - twist. Decreased exercise tolerance and altered LV function may be related to this.
2:30 p.m.
1023-32	 Longitudinal	Changes	in	Chronotropic	Response	to	
Exercise	and	Heart	Rate	Recovery	in	Pediatric	Heart	
Transplant	Recipients
Tajinder P. Singh, Kimberlee Gauvreau, Jonathan Rhodes, Elizabeth D. Blume, 
Children’s Hospital Boston, Boston, MA
Background: Sympathetic and parasympathetic innervation of the transplanted heart is 
completely interrupted by transplantation surgery. This denervation results in an abnormal 
chronotropic response to exercise characterized by depressed peak heart rate (HR) and 
delayed HR recovery. The purpose of this study was to assess whether the pediatric 
heart transplant recipient’s chronotropic response to exercise and HR recovery following 
exercise evolve over time in a manner consistent with autonomic re-innervation.
Methods: We analyzed a total of 149 maximal treadmill exercise tests (Bruce protocol) 
performed serially in a clinical protocol in 44 clinically well heart transplant recipients 
(median 4 tests per patient, range 2-8 tests). The median age at transplant was 10.6 years 
(range 0.2-16.1 years), median age at first exercise test 12.3 years (range 5.8-18.5 years) 
and median duration from heart transplant to first exercise test 1.1 years (range 0.5 to 8.2 
years). Longitudinal changes in peak HR, percent-predicted peak HR and HR recovery 1- 
and 3-minutes from peak exercise were assessed using linear mixed models.
Results: Peak HR increased with time since transplant (mean change 2.4 beats per 
minute (bpm)/year since transplant, P < 0.001) with mean predicted peak HR of 156, 
161, 166 and 171 bpm 2, 4, 6 and 8 years after transplant. Consequently, the percent-
predicted peak HR increased over time (mean change 1.5 % per year since transplant, 
P < 0.001). Peak HR was 75 %, 78 %, 81 % and 84 % predicted 2, 4, 6 and 8 years after 
transplant. The improvements in peak HR were associated with parallel improvement in 
HR recovery. The 1-minute HR recovery increased by 0.7 bpm/year (P=0.01, mean 1-min 
HRR 9.5, 10.9, 12.4, 13.9 bpm 2, 4, 6 and 8 years after transplant) and 3-minute HR 
recovery by 2.3 bpm/year (P <0.001, mean 3-min HR recovery 26, 31, 35 and 40 bpm 2, 
4 , 6 and 8 years after transplant).
Conclusions: The pediatric heart transplant recipient’s chronotropic response to exercise 
and HR recovery on cessation of exercise improve progressively in the years following 
transplant. This observation suggests that cardiac autonomic re-innervation occurs with 
time in pediatric heart transplant recipients.
2:30 p.m.
1023-33	 Home	Surveillance	is	Warranted	In	Patients	With	
Systemic	To	Pulmonary	Artery	Shunts
Martha L. Clabby, Brian E. Kogon, Paul M. Kirshbom, Kirk R. Kanter, William T. Mahle, Children’s 
Healthcare of Atlanta, Atlanta, GA, Emory University School of Medicine, Atlanta, GA
Background: Home surveillance improves interstage mortality after Norwood procedure 
for hypoplastic left heart syndrome (HLHS). Patients with Blalock-Taussig (BT) shunts are 
also vulnerable, but the need for intensive surveillance of this group is unclear.
Methods: We reviewed our institutional experience of all patients undergoing BT shunt at < 90 
days of age from 1/2002 to 1/2006. Hospital surgical mortality, interstage mortality and risk factors 
for sudden death were reviewed. Patients with HLHS/variants s/p Norwood were excluded.
Results: 137 patients underwent BT shunt. The diagnoses were tetralogy of Fallot(TOF)(26), 
pulmonary atresia(PA) with ventricular septal defect(24), PA & intact ventricular septum(PA/
IVS)(21), tricuspid atresia(21), transposition of the great arteries & VSD & pulmonary 
stenosis(11), single ventricle/PA(17) and other two ventricle lesions(17). Median age 
at shunt was 8 days (range 1-85 days); wt was 3.08 kg ±0.76. Overall mortality was 
16.8%(23/137); hospital mortality was 7%(10/137). Interstage mortality (death between 
hospital discharge and next repair) was 10.2%(13/127); mean age at interstage death was 
91 days ± 53. Most interstage deaths, 8/13(62%), occurred at home without warning. The 
mean time from last cardiac evaluation to death was 8 days (range 0 to 24 days), and 38% 
of patients were seen by a cardiologist within 3 days of death. Lower wt at surgery (2.6 
±0.7vs 3.2±0.7 kg, p< 0.002) & smaller shunt(p=0.04) were risk factors for death. Patients 
with PA/IVS had highest risk of hospital death: 7/22 (21%), p=0.03. There was no difference 
in interstage mortality in patients with single ventricle vs. two-ventricle lesions(15% vs 13%, 
p=0.46). Notably, interstage mortality for TOF was 16% (4/25).
Conclusions: Patients with BT shunts, either single ventricle or two ventricle, have similar 
risk of interstage death; this parallels the reported interstage mortality after Norwood. While 
lower wt at surgery, and smaller shunt are predictors of mortality risk, death in this population 
remains unpredictable and close surveillance is warranted. Scrutiny of “asymptomatic” 
patients might reveal antecedents of sudden death, and improve outcomes.
2:30 p.m.
1023-48	 Aristotle	Comprehensive	Complexity	Score	is	not	
Better	Than	Analysis	of	Variance	in	Predicting	Hospital	
Length	of	Stay	After	Congenital	Heart	Surgery
William M. DeCampli, Patricia Sieffert, David Nykanen, Harun Fakioglu, Arnold Palmer 
Hospital for Children, Orlando, FL
Background: The Aristotle comprehensive complexity score (CCS) has been developed 
to predict performance in congenital heart surgery. Recently, CCS was shown to be only a 
weak predictor of mortality. Whether CCS predicts post-operative hospital stay (HLOS) is 
still unknown. We compared the use of CCS to standard multivariate analysis of variance 
(ANOVA) in predicting HLOS.
Methods: Using a database of our most recent 450 surgical cases from a single institution, 
we calculated HLOS and determined CCS using the Aristotle Institute algorithm. The five 
deaths were excluded. We calculated goodness of fit (R2 = square of regression coefficient) 
of log (HLOS, days) vs. CCS using linear regression. We used the identical data set to 
identify determinants of HLOS using ANOVA, beginning with the following five variables: 
procedure complexity (using the RACHS-1 score), presence of other system anomalies or 
syndromes, pre-operative shock, pre-maturity (<36 wks), and weight < 2.5 kg.
Results: Median HLOS was 5 days (range 1 to 83). Median CCS score was 9.0 (range 
3 to 17). R2 = 0.55 for CCS regression (p<.0001). Final model was log (HLOS) = .097 
(CCS) - .075. R2 = 0.60 for ANOVA (p<.0001). Determinants were RACHS-1 score and 
wt<2.5kg. (both p<.0005). Both models accounted for 55-60% of the observed HLOS 
variability. The root mean square difference in residuals between the two methods was 
high (0.22), indicating that the models were not homologous or identical.
Conclusion: In this single institution data set, CCS was no better than five-variable ANOVA 
in predicting HLOS after congenital heart surgery. The two models were not identical 
and 40% of HLOS variability was due to undefined factors. The Aristotle score requires 
continued refinement and validation testing, and its limits of applicability must be defined.
2:30 p.m.
1023-49	 Alterations	in	Perioperative	Doppler	Indices	of	Diastolic	
Function	Predict	Postoperative	Course	in	Children	
Undergoing	Congenital	Heart	Surgery
Joanna B. Rosenthal, Jong-Hau Hsu, Michael M. Brook, Roberta L. Keller, Jeffrey R. 
Fineman, Theresa A. Tacy, University of California, San Francisco, San Francisco, CA
Background: Although mortality following repair for congenital heart disease has 
decreased, post-operative morbidities, such as low cardiac output syndrome (LCOS) and 
prolonged ventilation, remain prevalent. Early identification of patients at risk for these 
complications could help guide post-operative management. Previous studies have 
demonstrated that: 1) Doppler indices of left ventricular filling pressure (E/E’) predict 
cardiac death or re-hospitalization for heart failure in adults, and 2) the 12-hour post-
operative B-type natriuretic peptide (BNP) level is associated with duration of ventilation 
and the presence of LCOS after cardiac surgery in children. We hypothesize that elevated 
peri-operative left ventricular E/E’ is associated with LCOS, prolonged ventilation, and 
increased BNP following pediatric congenital heart surgery.
Methods: Thirteen children (0.2 to 15.8 yrs) undergoing cardiac surgery with 
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cardiopulmonary bypass (CPB) were enrolled. Transesophageal echocardiography was 
performed pre and post-operatively. Early transmitral flow velocities (E) and Doppler tissue 
imaging of annular motion (E’) were performed during both studies. The post-operative 
clinical course was reviewed; duration of ventilation and LCOS episodes recorded. LCOS 
was defined by a predetermined scoring system and prolonged ventilation was defined 
as longer than 48 hours. Arterial BNP was measured preoperatively and at 2,12 and 24 
hours after CPB. Data were analyzed by nonparametric methods.
Results: There was a significant difference in pre-operative mitral E/E’ in patients who 
developed LCOS (n=5, mean 17.1+/-SD 6.3), vs. patients who did not (n=8, 9.7+/-1.9; 
p=0.02), and in patients with prolonged ventilation (n = 5, 15.1+/-5.5), vs. those without 
(n=8, mean 10.9+/-5.0; p=.04). Both pre- (R=0.72, p=.008) and post-operative E/E’ 
(R=0.73, p=0.007) correlated with 12 hour BNP.
Conclusions: An elevated pre-operative mitral E/E’, may herald the development 
of low cardiac output syndrome and/or prolonged ventilation in children undergoing 
congenital heart surgery. These Doppler indices may be a useful tool for clinicians 
caring for children after congenital heart surgery.
2:30 p.m.
1023-50	 Clinical	Significance	of	Mitral	Valve	Prolapse	in	Adult	
Patients	with	Atrial	Septal	Defect
Manatomo Toyono, Shota Fukuda, Nozomi Wada, Yoshiki Matsumura, Gosta Petterson, 
James D. Thomas, Takahiro Shiota, The Cleveland Clinic Foundation, Cleveland, OH
Background: Mitral valve prolapse (MVP) in patients with atrial septal defect (ASD) is 
frequently asymptomatic. In older patients, however, progressive mitral valve deterioration 
may result in clinically significant mitral regurgitation (MR).
Objectives: To examine the prevalence of MVP and relation between MVP and MR in 
adult patients with ASD before and after surgical closure.
Methods: We examined 71 patients (47 ± 16 years, male 32%) undergoing ASD surgical 
closure and 30 age- and gender-matched controls. No ASD patients showed organic mitral 
valve disease except MVP. Occurrence of atrial fibrillation and echocardiographic variables 
including left (LV) and right ventricular size, LV and right ventricular function, and grades of 
MR and tricuspid regurgitation (TR) were investigated before and after surgery.
Results: The anatomy of ASD was ostium secundum in 55 (77%), sinus venosus in 15 
(21%), and unroofed coronary sinus in 1 (2%). Before ASD closure, 27 patients (38%) 
had MVP; prolapse of anterior leaflet in 22 and both anterior and posterior leaflets in 5. In 
patients with MVP, the occurrence of atrial fibrillation, left atrial area, minimal mitral valve 
annulus diameter, and the ratio of maximal MR area to left atrial area were significantly 
increased as compared with controls and patients without MVP (all p < 0.05). Prevalence of 
significant MR (the ratio of maximal MR area to left atrial area > 0.2) was higher in patients 
with MVP (48%) as compared with patients without MVP (2%, p < 0.001). In patients with 
MVP, severity of MR showed significant correlation with the ratio of maximal TR area to 
right atrial area (r = 0.64, p < 0.001). Surgery for MR concomitant with ASD closure was 
performed in 10 patients; ring annuloplasty in 9 and replacement in 1. In the 10 patients with 
corrective surgery for MR, LV end-diastolic volume, left atrial area, and severity of MR were 
significantly decreased after surgery (all p < 0.05). In 61 patients without surgery for MR, 
ASD closure alone decreased the prevalence of MVP (from 34% to 13%, p = 0.005).
Conclusion: MVP was seen in 38% of adult patients with ASD and resulted in significant MR 
associated with TR. Prevalence of MVP could be decreased by surgical closure of ASD alone.
2:30 p.m.
1023-51	 The	Utility	of	Measuring	Heart	Rate	Recovery	After	
Exercise	Testing	to	Risk	Stratify	Adults	with	Congenital	
Heart	Disease
Richard A. Krasuski, Alfred V. Rathinam, Mark Bastawros, Richard Lorber, Michael S. 
Lauer, Richard Sterba, The Cleveland Clinic, Cleveland, OH
Background: Exercise capacity is reduced in adults with congenital heart disease (CHD) 
compared to age-matched controls and appears to influence clinical prognosis. The 
utility of measuring heart rate recovery following exercise testing, an easily obtained and 
powerful risk-stratifying tool in patients with other types of structural heart disease, has 
not been previously examined in this patient population.
Methods: 145 adults with CHD and stable clinical status underwent cardiopulmonary 
exercise testing (CPX). Heart rate recovery (HRR) was calculated by subtracting 1-
minute post-CPX heart rate from the maximal heart rate during exercise, and 12 beats 
or less (the most widely validated definition) was identified as abnormal. Subjects were 
followed for a median of 44 months and cardiothoracic surgery, cardiac transplantation 
and all-cause mortality were predefined as clinical endpoints.
Results: 184 major congenital lesions were present in the 145 patients, including 
28 great vessel transpositions (18 D-loop and 10 L-loop), 25 aortic coarctations, 17 
ventricular septal defects and 17 pulmonic stenoses. The mean age was 31±13 years 
(range 18-83), 46% were women and 88% were Caucasian. Abnormal HRR was present 
in 30% of patients tested. The VO2 max was significantly reduced in those patients with 
abnormal HRR (29.4±8.8 vs. 22.7±7.3 ml/kg/min, p<0.001). During follow-up 22 major 
events occurred, including 15 surgeries (1 cardiac transplant) and 7 deaths. Only the 
VO2max predicted major clinical events (p=0.048). Both a reduced VO2max (p=0.015) 
and abnormal HRR (p=0.026), however, were found to increase the risk of subsequent 
death or transplantation. Patients with an abnormal HRR were almost 6 times more 
likely to die or undergo transplantation than patients with normal HRR. The VO2max 
among this latter group was severely reduced (17.7 vs. 26.6 ml/kg/min in surviving non-
transplanted patients, p=0.051).
Conclusions: Abnormal heart rate recovery after exercise testing appears to identify 
an extremely high risk subset of adults with CHD. It may provide an easily measured 
alternative for determining prognosis, particularly if formal metabolic assessment is not 
available or not feasible.
ACC.ORAL CONTRIBUTIONS
823 
Pediatric	Cardiovascular	Disease
Monday, March 26, 2007, 4:00 p.m.-5:30 p.m.
Room 228-229-230
4:00 p.m.
823-3	 Fetal	Hemodynamic	Instability	During	Prenatal	Cardiac	
Intervention:	Risk	Factors,	Management,	and	Outcome
Doff B. McElhinney, Wayne Tworetzky, Linda A. Bulich, Louise E. Wilkins-Haug, Audrey 
C. Marshall, Carol B. Benson, James E. Lock, Arielle Mizrahi-Arnaud, Children’s 
Hospital, Boston, MA, Brigham and Women’s Hospital, Boston, MA
Background: Fetuses with valvar obstruction and impending hypoplastic left (HLH) or 
right (HRH) heart syndrome, with or without an intact atrial septum (IAS), may benefit from 
prenatal cardiac intervention (PCI). Predictors and impact of fetal hemodynamic instability 
(FHI) during PCI and responses to resuscitation are undescribed.
Methods: We reviewed our experience with PCI to assess risk factors for FHI (bradycardia 
<100 bpm and ventricular dysfunction lasting ≥1 min and/or treated with resuscitation 
medications and fetal thoracic “compression”). FHI was classified as minor (<5 min and/or 
untreated) or major (≥5 min and treated).
Results: From 2000-06, 80 fetuses underwent PCI for impending HLH (56), HLH/IAS (16), 
or impending HRH (8), with transuterine fetal cardiac access by direct puncture. PCI was 
successful in 63 fetuses (79%). Minor (14) or major (20) FHI occurred in 34 fetuses (43%), 
and was treated with intracardiac and/or intramuscular epinephrine in 28, plus intracardiac 
atropine in 5. All fetuses regained normal heart rate and ventricular function after 1-32 min. 
The procedure was continued with additional cardiac puncture but no further FHI in 11 
fetuses, completed successfully before/during FHI in 17, and aborted in 6. FHI occurred 
in 34/64 fetuses (53%) with ventricular access and 0/16 with atrial access only (p<0.001). 
FHI was associated with unsuccessful PCI (p=0.02). Of 56 fetuses with impending HLH, 
28 (50%) had minor (12) or major (16) FHI; major FHI was associated with shorter left 
ventricular (LV) length (1.5±0.4 v 1.9±0.4cm, p=0.02) and smaller LV short-axis diameter 
(1.1±0.2 v 1.4±0.4cm, p=0.01). Moderate/ large hemopericardium (8) was associated with 
FHI (p=0.02). Of 6 fetal deaths within 72 hrs, 4 had FHI (p=0.05).
Conclusion: FHI was common during PCI with ventricular access, but did not occur in 
fetuses with transatrial access only. Fetuses with impending HLH and a smaller LV are at 
risk for FHI. FHI resolved acutely in all cases, and PCI usually continued after resuscitation 
without additional FHI. Though post-PCI fetal demise is uncommon, fetuses with FHI are 
at increased risk. Methods to prevent FHI during PCI are most needed for fetuses with 
impending HLH and a smaller LV.
4:15 p.m.
823-4	 6	Years’	Experience	Of	Outcome	After	Percutaneous	
Pulmonary	Valve	Implantation
Philipp Lurz, Johannes Nordmeyer, Louise Coats, Sachin Khambadkone, Graham 
Derrick, Seamus Cullen, John Deanfield, Younes Boudjemline, Andrew Taylor, Philipp 
Bonhoeffer, UCL Institute of Child Health and Great Ormond Street Hospital for 
Children, London, United Kingdom, The Heart Hospital, London, United Kingdom
Background: In 6 years of experience with percutaneous pulmonary valve insertion, we have 
now collected sufficient information to make the first mid term evaluation of this technique.
Methods: Peri- and post-procedural complications led to explantation of the device. We 
sought to analyse the influence of learning curve and technique modification on freedom 
of explantation. Therefore, the patient population was divided into a first cohort of initial 50 
Patients, and a second group of patients, who underwent PPVI after improvement of device 
and technique. Survival curves for freedom of explantation were calculated for both cohorts.
Results: During follow-up, 19 out of 137 patients underwent stent explantation.
Two types of reasons for device explanation were identified. Type 1 (hammock effect n=4, 
stent fractures n=1, valve dislodgement n=2, coronary compression n=1, right pulmonary 
artery obstruction n=1 and residual stenosis n=6) led to modification of the technique 
(device alterations, second PPVI, enhance imaging and improved patients selection).
In group two, no modification of the technique could be suggested with current knowledge 
(endocarditis n=2, outgrown conduit n=1 and homograft rupture n=1). Change in technique 
resulted in a significant improvement in freedom of explantation (P<0.05, Figure).
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Conclusions: Overall experience proves, that PPVI is a reasonable alternative to 
surgery. The learning curve demonstrates that better results are achieved and can be 
expected in future. 
4:30 p.m.
823-5	 The	UK,	Ireland	and	Sweden	Collaborative	Study	of	
Pulmonary	Vein	Stenosis:	Spectrum	of	Morphology
Anna N. Seale, John Partridge, Hideki Uemura, Siew Y. Ho, Karen P. McCarthy, Sheila 
Jones, Lynda Shaughnessy, Jan Sunnegardh, Katarina Hanseus, Steven A. Webber, 
Michael L. Rigby, Barry R. Keeton, Piers E. Daubeney, The Royal Brompton Hospital on 
behalf of the British Congenital Cardiac Association, London, United Kingdom
Background: Pulmonary vein stenosis (PVS) is a serious condition in infants and 
children often leading to progressive pulmonary hypertension and death. Outcome is 
likely to be dependent on presenting morphology which needs further clarification. We 
aimed to define the spectrum of morphology and assess patterns of progression.
Methods: Retrospective international collaborative study involving 19 paediatric 
cardiology centres in the UK, Ireland and Sweden. All cases of PVS presenting between 
1/1/1995 and 31/12/2004 were identified using hospital databases. Only cases where 
the pulmonary veins (PV) connected to a morphological left atrium (LA) were included. 
Cases were excluded if there had been previous repair of total anomalous pulmonary 
venous connection or if the heart was functionally univentricular. All available data and 
imaging were reviewed.
Results:	 Fifty-eight cases were identified. Forty-six (79%) had associated cardiac 
lesions, 41 a left-to-right shunt. Fifteen (26%) had undergone previous cardiac surgery 
prior to PVS diagnosis. Thirty-six presented with unilateral disease of which 31 had left PV 
involvement. Anatomy of the PV connection to LA was variable and could be described 
in 45 patients. Twenty-four (53%) had a common stenotic PV entering the LA; in 2 all the 
PVs united into a confluence with a stenosed orifice communicating directly with the LA; 
in the remainder the PVs entered the LA individually. Invariably the stenosis was discrete 
at the connection of the PV or common vein. In 14 progression of the disease was imaged 
over time. An initial discrete stenosis tended to lead to PV hypoplasia and, if unilateral, 
a small pulmonary artery on the affected side. Frequently collateral vessels developed 
draining to systemic or adjacent pulmonary veins.
Conclusion:	PVS has considerable morphologic heterogeneity characterised by discrete 
stenosis and variable degree of vein hypoplasia that progress over time. A role for early 
intervention may be indicated to relieve obstruction before secondary and irreversible 
changes occur.
4:45 p.m.
823-6	 Factors	Associated	with	Serum	Brain	Natriuretic	
Peptide	Levels	in	Patients	after	the	Fontan	Procedure
Andrew M. Atz, Page AW Anderson, Roger E. Breitbart, Steven D. Colan, Paul D. 
Mitchell, Daphne T. Hsu, Minmin Lu, Lynn Mahony, Stephen M. Paridon, Richard V. 
Williams, Brian W. McCrindle, Medical University of South Carolina, Charleston, SC
Background: Levels of serum brain natriuretic peptide (BNP) are elevated in congestive 
heart failure and have prognostic importance for patients with biventricular circulations. 
Their relevance for single ventricle patients has not been well-defined.
Methods: A sample of 510 patients (60% male) participating in the NIH Pediatric Heart 
Network (PHN) Fontan Cross-Sectional Study underwent exercise testing and had BNP, 
echocardiogram, and magnetic resonance images (MRI) assessed in core laboratories. 
Stepwise regression investigated associations of medical history and test variables with 
BNP. Reported results are significant at p<0.05.
Results: Patients had a median age of 11.4 years (inter-quartile range: 9.0, 14.6) and 
were studied at a median of 8.2 years (5.9, 11.3) after their Fontan procedure. The 
distribution of BNP was highly skewed, with a median of 13.0 pg/mL (7.1, 25.9), and was 
normalized with logarithmic transformation (logBNP). LogBNP was independently greater 
in females and older patients. LogBNP was significantly related to Fontan connection 
type even after adjustment for age, with the lowest levels seen in those with extracardiac 
conduits, followed by extracardiac and intracardiac lateral tunnels, and highest levels 
for those with atriopulmonary connections. Lower physical functioning assessed from 
the Child Health Questionnaire was associated with higher levels of LogBNP. During 
exercise testing, lower resting oxygen saturation, lower peak oxygen consumption, lower 
maximum heart rate, and lower heart rate at anaerobic threshold were associated with 
higher LogBNP. Higher total ventricular mass assessed by echocardiography and MRI 
was related to higher LogBNP. Medical history variables associated with higher logBNP 
were lower systemic oxygen saturation and greater weight at Fontan, and ventricular 
dysfunction at hospital discharge after Fontan.
Conclusions: The distribution of BNP levels in the Fontan population is lower than 
reported values seen in congestive heart failure. Serum BNP levels are associated with 
surgical subtype, physical functioning, ventricular mass, and exercise capacity. Monitoring 
of BNP levels in Fontan patients may be indicated.
5:00 p.m.
823-7	 Accuracy	of	Right	Ventricular	Size	Assessment:	
Echocardiography	Versus	Magnetic	Resonance	Imaging	
Wyman W. Lai, Ernesto S. Rivera, Susan Saleeb, Kimberlee Gauvreau, Andrew J. 
Powell, Tal Geva, Children’s Hosptial Boston, Boston, MA
Background: The American Society of Echocardiography (ASE)-published guidelines 
recommend several measurements for the quantification of right ventricular (RV) size but 
their accuracy has not been assessed in pts with RV dilation.
Methods: Pts with clinical echo and MRI studies less than 6 months apart were identified. 
A normal RV control group and two groups with RV dilation were selected: 1) repaired 
tetralogy of Fallot, and 2) atrial septal defect and/or partially anomalous pulmonary 
venous connection (PAPVC). ASE-recommended RV linear and 4-chamber area 
measurements were made from echo and MRI images. MRI-derived RV end-diastolic 
volume (EDV) served as the reference standard. Based on the normal RV group, z-scores 
were generated. Echo and MRI measurements were compared using paired t-tests; 
associations between echo/MRI measurement and RV EDV z-scores were quantified.
Results: ASE-recommended linear and 4-chamber area measurements were smaller by 
echo than by MRI (p<0.05 for all). Pearson correlation coefficients between RV EDV and 
the ASE-recommended measurements by echo and MRI are shown in the table.
Conclusion: In pts with and without RV dilation, the ASE-recommended linear and 
4-chamber area measurements correlated poorly with RV EDV when made by echo, 
and correlated only modestly when made by MRI. These findings suggest that accurate 
assessment of RV size likely requires 3D measurement techniques. 
Normal RV TOF ASD/PAPVC
n=31 n=33 n=23
Median age 16 yr (4-46 yr) 21 yr (4-57 yr) 14 yr (0.5-60 yr)
RV EDV by MRI (ml) 133+58 259+91 186+113
ECHO MRI ECHO MRI ECHO MRI
Basal diam 0.37* 0.56* 0.33 0.44* 0.52 0.28
Mid RV diam 0.34 0.37 0.46* 0.45* 0.56* 0.52
Base-apex 0.26 0.56* 0.37* 0.50* 0.32 0.68*
RV D area 0.45* 0.61* 0.58* 0.69** 0.66* 0.74*
*p<0.05, **p<0.001; Abbreviations: D-diastolic, diam-diameter
5:15 p.m.
823-8	 Age	at	Bidirectional	Glenn	Procedure	and	Mortality:	
A	Multi-Center,	International	Registry
Annette K. Ansong, Eric Yow, Katherine Berezny, Jutta von Stieglitz, Jennifer S. Li, Duke 
University Medical Center, Durham, NC, Duke Clinical Research Institute, Durham, NC
Background: The optimal age at which to perform a bidirectional Glenn (BDG) procedure 
in children with single ventricle is not known.	Advantages of early surgery are early 
elimination of volume load and establishment of a more stable source of pulmonary 
blood flow. Complications due to issues related to pulmonary vascular resistance in 
young infants, however, can be significant.	We sought to determine if a younger age (< 4 
months) at BDG is associated with a higher mortality.
Methods: We collected data from 13 centers in the US, France, and Germany. Records 
of infants operated between 2001-2004 were evaluated and follow-up data were obtained 
1 yr after their first palliative procedure. Patients who underwent the BDG operation were 
divided into two groups, early (0-4 months of age) and later BDG (5-12 months of age). 
Death was the outcome variable used for comparison. A Cox regression model was 
constructed for time to death or 1 year with time dependent covariate terms for early 
BDG and later BDG. The model was adjusted for age at procedure, ASA use, cardiac 
diagnosis, and center.
Results: A total of 877 patients with single ventricle were evaluated: hypoplastic left heart 
syndrome (n=346), pulmonary atresia (n=177), tricuspid atresia (n=103), heterotaxy 
syndrome (n=38), other (n=213).	A total of 337 survived their first palliative procedure 
and underwent BDG (early BDG, 30/377).	Of those who underwent an early BDG, 16.7% 
of deaths occurred compared to the 6.5% in the late BDG group. In addition, patients who 
underwent an early BDG were at greater risk of death than the late group [HR=3.59, CIs 
1.38, 9.31, p-value: 0.009].
Conclusions: Although this study does not differentiate between those patients needing 
early BDG and those receiving it due to center preference, patients receiving an early 
BDG are at risk for higher mortality. Further studies are needed to be able to adequately 
select patients for early surgery.
ACC.ORAL CONTRIBUTIONS
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837-3	 Cardiopulmonary	Exercise	Function	Predicts	Long-term	
Prognosis	in	Adults	With	Repaired	Tetralogy	of	Fallot
Alessandro Giardini, Salvatore Specchia, Andrea Donti, Gaetano Gargiulo, Roberto 
Formigari, Fernando Maria Picchio, Pediatric Cardiology and Adult Congenital Unit, 
University of Bologna, Italy, Bologna, Italy, Institute of Cardiology, University of Bologna, 
Italy, Bologna, Italy
Background: Adults with repaired tetralogy of Fallot (ToF) have increased long-term 
mortality. The identification of patients at higher risk of death or cardiac-related morbidity 
is challenging. We sought to assess the prognostic value of cardiopulmonary exercise 
test (CPX) in adults with repaired ToF.
Methods: One hundred eighteen consecutive adults with repaired ToF (mean age at 
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repair 4.8±4.2 years) underwent CPX test at a mean age of 24±8 years (range 16 to 
59). The degree of pulmonary regurgitation, right ventricular systolic function and right 
ventricular systolic pressure were determined by transthoracic echocardiography. After 
CPX, patients were regularly followed-up for cardiac-related events.
Results: At a follow-up of 5.8±2.3 years (range 0.6 - 9.7 years), 9 patients died (5 suddenly, 
4 because of progressive right ventricular failure) and 18 underwent hospitalization 
(arrhythmias in 8 patients, right ventricular failure in 10). The prognostic value of peak 
oxygen uptake (VO2), slope of ventilation per unit of carbon dioxide production (VE/VCO2 
slope), and clinical and echocardiographic variables was assessed with univariate and 
multivariate Cox proportional risks analyses. Peak VO2 (hazard ratio 0.974, 95% CI 
0.950-0.994), VE/VCO2 slope (hazard ratio 1.076, 95% CI 1.038-1.115), and New York 
Heart Association functional class (hazard ratio 2.118, 95% CI 1.344-3.542) were the 
only independent predictors of death or hospitalization. Patients with a peak VO2 ≤ 36% 
of predicted value (sensitivity 88.9%, specificity 100% at receiver-operator characteristic 
analysis) and those with a VE/VCO2 slope > 39 (sensitivity 100%, specificity 98.2%) were 
at higher risk of cardiac-related death (5 years mortality 48% vs. 0%, p<0.0001; and 31% 
vs. 0%, p<0.0001, respectively).
Conclusions: In adults with repaired ToF, CPX with measurement of peak VO2 and 
VE/VCO2 slope can be prognostically important and could turn into a powerful tool to 
rationalize decisions regarding the prevention of premature sudden death and the need 
for re-interventions.
9:15 a.m.
837-4	 Ventilatory	Efficiency	and	Heart	Rate	Response	are	
the	Strongest	Exercise	Markers	of	Outcome	in	Non-
Cyanotic	Adults	with	Congenital	Heart	Disease
Gerhard-Paul Diller, Konstantinos Dimopoulos, Leah R. Benson, Michael A. Gatzoulis, 
Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton 
Hospital, London, United Kingdom
Background	 - Peak oxygen consumption (pVO2), VE/VCO2 slope and parameters of 
heart rate response were recently identified as strong predictors of mortality in adults 
with congenital heart disease. We sought to compare the prognostic power of exercise 
parameters in a large population of adults with congenital heart disease (ACHD).
Methods	- Cardiopulmonary exercise testing was performed in 1005 consecutive ACHD patients 
(age 33.9±13.6 years, 53.3%male) with varying diagnoses. PeakVO2, anaerobic threshold (AT), 
VE/VCO2 slope and heart rate reserve (HRR=peak minus resting heart rate) were calculated.
Results	 - During a median follow-up of 37.1 months, 60 (6.0%) patients died. On 
univariate Cox analysis, all exercise parameters were strongly associated to death in 
the non-cyanotic population (p<0.005 for all), whereas in cyanotic patients only HRR 
was predictive of outcome (HR per 10-bpm increase=0.82, 95%CI:0.69-0.99, p=0.044). 
On stepwise forward multivariate Cox analysis, VE/VCO2 slope (HR per 10-unit 
increase=1.27, 95%CI: 1.05-1.53, p=0.01) and HRR (HR per 10-bpm increase=0.76, 
95%CI: 0.67-0.86,p<0.0001) were the only independent predictors of all-cause mortality 
in non-cyanotic patients, whereas pVO2 and AT were not retained in the model.
Conclusions: VE/VCO2 slope and HRR are the strongest exercise predictors of survival 
in adults with non-cyanotic ACHD and, in combination, they provide an invaluable clinical 
tool for risk stratification in this challenging group of patients.
9:30 a.m.
837-5	 Children	and	Adults	With	Congenital	Heart	Disease	
Lost	to	Follow-up:	Who	and	When?	A	Population-
Based	Study
Andrew S. Mackie, Raluca Ionescu-Ittu, Judith Therrien, Louise Pilote, Ariane J. Marelli, 
McGill University Health Centre, Montreal, PQ, Canada
Background:	Duration of cardiology follow-up in children and adults with congenital 
heart disease (CHD) is unknown. We determined the change in proportion of children 
and young adults with CHD receiving outpatient cardiology care in a population where 
access to health care is universal.
Methods:	The study population consisted of individuals born in l983 and alive at age 
22 who were diagnosed with CHD by a cardiologist in Quebec, Canada before 6 years 
of age (N=563). Patients and outpatient visits were identified using the provincial 
physician’s claims database. Subgroup analysis is shown for Group 1 (tetralogy of Fallot, 
transposition, endocardial cushion defect, coarctation, N=125) and Group 2 (atrial and 
ventricular septal defects, N= 306). Subgroups were compared using chi square tests.
Results:	Only 28% of the entire cohort was still being followed in early adulthood. Failure 
to be seen by a cardiologist occurred in 41% (ages 6-12), 62% (ages 13-17), and 72% 
(ages 18-22). The drop off in follow-up was significantly higher in Group 2 than in Group 
1 (p<0.0001).
Conclusions:	 In patients with CHD, the largest drop off in outpatient cardiology care 
occurs in pre-adolescence. Even among patients with lesions that generally warrant 
lifelong follow-up (Group 1), a substantial proportion of patients were no longer being 
seen within the pediatric age range. Planning effective transition of care into adulthood 
should start before adolescence.
9:45 a.m.
837-6	 Changing	Age	Distribution	of	Death	in	Congenital	Heart	
Disease	from	1988	to	2005:	a	Population	Based	Study
Paul Khairy, Andrew S. Mackie, Raluca Ionescu-Ittu, Louise Pilotte, Ariane J. Marelli, 
McGill University Health Center, Montreal, PQ, Canada, Montreal Heart Institute, 
Montreal, PQ, Canada
Background:	Historically, young children have constituted the age group with the highest 
mortality from congenital heart disease (CHD). We assessed age specific mortality trends 
over an 18-year period in a contemporary population based cohort with CHD.
Methods:	The study population consisted of all individuals ≥1 year of age with at least one 
diagnostic code for CHD between 1983 and 2005 conforming to the ICD-9 classification 
in the physician’s claim database of Quebec. Overall and lesion-specific mortality rates 
stratified by age category were determined and compared between 1988 and 2005.
Results:	 A total of 8,123 deaths occurred in 71,460 patients with CHD followed for 
1,008,835 patient-years. From 1998 to 2005, the crude death rate increased from 4.62 to 
10.47 per 1000 patient-years (P<0.0001). Age of death steadily increased over time as 
the distribution transitioned from a bimodal to single peak albeit skewed pattern, depicted 
in Figure 1. Overall median age of death increased by 7 years from 1988-1993 to 2000-
2005 (P<0.0001). Similar trends were noted for most congenital subtypes including 
tetralogy of Fallot (5 versus 41 years, P<0.0001), transposition of the great arteries (6 
versus 31 years, P=0.001), atrial (65 versus 71 years, P=0.0001), and ventricular (61 
versus 69 years, P=0.0004) septal defects.
Conclusion:	Deaths in CHD have shifted away from the young and towards the adult, 
with increasing absolute numbers and mortality rates. The healthcare community must 
prepare to meet this new reality. 
10:00 a.m.
837-7	 Effects	of	Ramipril	on	Endothelial	Function	And	
Inflammatory	Process	In	Young	Normotensive	Patients	
With	Succesfully	Repaired	Coarctation	Of	The	Aorta
Stella Brilli, Dimitris Tousoulis, Charalambos Antoniades, Maria Karali, Nikos Papageorgiou, 
Carmen Vassiliadou, Christos Pitsabos, Costas Tentolouris, Ilias Stamatopoulos, Andreas 
Bratsas, Christodoulos Stefanadis, Athens University, A Cardiology Department, Athens, Greece
Background: Coarctation of the aorta leads to impaired endothelial function in the 
pre-coarctation arterial tree and increased inflammatory process, which persists 
many years after successful surgical repair. We examined the effect of ramipril on 
endothelial function and inflammatory process in young normotensive subjects with 
JACC  March 6, 2007    ABSTRACTS - Pediatric Cardiology and Adult Congenital Heart Disease    269A 
P
ediatric C
ardiology and A
dult C
ongenital H
eart D
isease
successfully repaired coarctation of the aorta.
Methods: Twenty normotensive subjects with successfully repaired coarctation of the 
aorta 11.4±1.3 years ago, were randomised to receive ramipril 5mg/d or no treatment 
for 4 weeks, in a randomised cross-over prospective trial with a 4 weeks washout 
period between interventions. Endothelial function was evaluated by gauge-strain 
plethysmography and endothelium dependent dilation (EDD) was determined. Values 
were expressed as means±SEM or median(25th-75th percentile) as appropriate.
Results: EDD was significantly improved after ramipril treatment (from 39.8±2.9% to 
49.0±3.1% p<0.05) but not after no treatment (from 42.0±2.2% to 44.1±2.1% p=NS). 
Maximum hyperaemic flow was also increased after ramipril (from 7.21±1.1 ml/100ml 
tissue/min to 8.9±1.0 ml/100ml tissue/min p<0.05) while remained unchanged in controls 
(from 8.04±1.4 to 7.8±1.2ml/100ml tissue/min, p=NS). Serum IL-6 was decreased after 
ramipril treatment (from 2.33[1.35-4.36] to 1.59[0.89-2.15] p<0.05) while remained 
unchanged in controls (from 1.14[0.87-4.19] to 1.45[0.92-4.43] p=NS). Serum IL-1b 
and CRP were slightly but not significantly decreased by ramipril (from 0.28[0.19-1.41] 
and 1.64[0.24-3.52] to 0.23[0.13-0.27] and 1.05[0.33-2.31] respectively, p=NS for both). 
Similarly, EID remained unchanged after both treatment with ramipril (from 56.6±5.6% to 
58.3±10.1% p=NS) or after no treatment (from 59.2±14.2% to 57.7±10.1% p=NS).
Conclusions:	 Ramipril significantly improves endothelium dependent dilation and 
decreases the expression of interleuin-6 in young normotensive subjects with successfully 
repaired coarctation of the aorta. Therefore, ramipril may have direct beneficial effects 
on vascular function and inflammatory process in patients with successfully repaired 
coarctation of the aorta.
10:15 a.m.
837-8	 Endothelial	Progenitor	Cells	in	Patients	with	
Eisenmenger	Syndrome	or	Idiopathic	Pulmonary	
Arterial	Hypertension
Gerhard-Paul Diller, Darlington O. Okonko, John S. Wort, Martin R. Wilkins, John 
Wharton, Michael A. Gatzoulis, Adult Congenital Heart Centre and Centre for Pulmonary 
Hypertension, Royal Brompton Hospital, London, United Kingdom, Department of 
Experimental Medicine and Toxicology, Imperial College London, London, United Kingdom
Background: Pulmonary arterial hypertension (PAH) is a vasculoproliferative disease 
characterized by endothelial dysfunction and a progressive increase in pulmonary 
vascular resistance (PVR) that elicits right ventricular failure and premature death. 
Circulating endothelial progenitor cells (EPCs) contribute to vascular repair.
Methods:	We recruited 24 patients with Eisenmenger syndrome (12 female, age 40±13 
yrs), 8 patients with idiopathic PAH (8 female, age 36±10 yrs) and 11 control subjects (4 
female, 34±4 yrs). Circulating EPCs were quantified using flow cytometry (% lymphocytes) 
and endothelial colony forming unit (CFU-E) assays.
Results:	 Circulating CD34+ ([mean±SD] 0.076±0.33 vs. 0.115±0.32%, p=0.02), 
CD34+/AC133+ (0.023±0.017 vs. 0.041±0.016%, p=0.03), and CD34+/AC133+/KDR+ 
(0.004±0.004 vs. 0.008±0.004%, p=0.01) stem cells were attenuated in Eisenmenger 
patients compared to healthy controls. Circulating CFU-E numbers were reduced in patients 
with Eisenmenger syndrome compared to controls (10.2±7.0 vs. 23.2±5.6; p=0.0002). 
Eisenmenger patients with Down syndrome had lower EPC numbers than those without 
(0.012±0.015 vs. 0.029±0.015% CD34+/AC133+, p=0.02). Lower EPC (CD34+/AC133+ 
and CD34+/AC133+/KDR+) numbers were associated with a worse NYHA functional class 
(p<0.05 for both) in Eisenmenger patients In contrast, the number of colonies and EPCs 
were equal to or greater than controls in patients with idiopathic PAH.
Conclusions:	Circulating EPCs are markedly diminished in patients with Eisenmenger 
syndrome. This reduction relates to an impaired functional capacity and is even more 
pronounced in patients with Down syndrome. This is in contrast to EPC numbers in 
patients with idiopathic PAH, suggesting that divergent pathogenetic mechanisms 
underlie PAH in these two cohorts.
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1029-27	 Prediction	Of	Right	Ventricular	Ejection	Fraction	From	
Color	Doppler	Tissue	Indices	In	Patients	With	Repaired	
Tetralogy	Of	Fallot
Shubhika Srivastava, Wyman W. Lai, Helen H. Ko, Ira A. Parness, James C. Nielsen, 
Irene D. Lytrivi, Mount Sinai Medical Center, New York, NY
Prediction of Right ventricular Ejection Fraction from Color Doppler Tissue Indices in 
Patients with Repaired Tetralogy of Fallot
Background: Decreased right ventricular (RV) ejection fraction (EF) increases morbidity 
in patients following Tetralogy of Fallot (ToF) repair. Magnetic resonance imaging (MRI)-
derived RV EF is the accepted reference standard for RV function assessment. Utility of 
color Doppler Tissue Indices (cDTI) to identify pts with decreased RV EF following ToF 
repair has not been established.
Methods: Consecutive pts with repaired ToF who underwent both MRI and 
echocardiography were studied. cDTI were used to compute RV EF utilizing linear 
discriminant analysis to estimate the probability of correctly classifying RV EF of <50%. 
The cDTI included were peak systolic velocity (pkS) and isovolumic acceleration (IVA) 
adjusted for age. The effect of pressure overload (RV > 1/2 systemic) and/or volume 
overload (dilated RV by qualitative echo assessment) was also evaluated.
Results:	30 sets of studies were performed on 26 patients, with median age 14.6 yrs, 
range 10-42.8 yrs. The MRI median RV EF was 46.6%, range of 32.7-55%, there were 
22 studies with RV EF < 50%. A linear discriminant function (LDF) using pkS adjusted 
for age correctly identified 72% patients with MRI-derived RV EF < 50%. Using IVA 
adjusted for age, 86% of patients with RV EF <50% were correctly identified. Using 
pkS, IVA, and age, LDF correctly identified 85% of the patients with RV EF <50%, r=0.7. 
The sensitivity and specificity of this predictive model in predicting RV EF <50% is 70% 
and 86%, respectively (p<0.0001) positive predictive value of 93%. The incorporation of 
volume and pressure overload along with cDTI did not increase the predictive value of 
the discriminant function.
Conclusion: The combination of pkS, IVA, and age by cDTI provide a sensitive and specific 
method in isolating patients with decreased MRI-derived RV EF (<50%). Assessment of RV 
function by echocardiography may provide an adjunct for clinical assessment but does not 
replace MRI in quantifying RV function in patients with repaired ToF.
10:00 a.m.
1029-29	 Alterations	in	Calcium	Cycling	Proteins	in	Pediatric	vs	
Adult	Heart	Failure
Tomislav Ivsic, Wendy E. Sweet, Geoffrey L. Rosenthal, Brian W. Duncan, Gerard J. 
Boyle, Christine S. Moravec, Cleveland Clinic, Cleveland, OH
Background:	 Gene therapy trials using SERCA (sarcoplasmic-endoplasmic reticulum 
calcium ATPase) and PLB (phospholamban) in the treatment of end-stage heart failure 
demonstrate acceptance of the fact that alterations in these proteins play a role in the adult 
failing heart. However, it is not clear whether the same changes occur in pediatric hearts.
Methods: Hearts from 7 pediatric non-failing (P-NF), 10 pediatric dilated cardiomyopathy 
(P-DCM), 10 adult non-failing (A-NF) and 10 adult DCM (A-DCM) patients were used. 
Hearts came from transplant or organ donation. Immunoblotting was used to measure: 
calsequestrin (CQ), sodium-calcium exchanger (NCX), SERCA, PLB and ryanodine 
receptor (RYR). PLB/SERCA ratio was calculated. Data were analyzed by 2-way ANOVA.
Results: Table shows densitometric units. SERCA was decreased in A-DCM vs A-NF, but 
unchanged in P-DCM vs P-NF. NCX was increased 2-fold in A-DCM and 4-fold in P-DCM 
vs NF. NCX levels were marginally greater at ages younger than 13 (p=.056). CQ, PLB, 
PLB / SERCA ratio and RYR did not differ between groups. 
Protein A-NF A-DCM P-NF P-DCM
CQ 1.19 ± 0.14 1.52 ± 0.28 1.69 ± 0.38 1.28 ± 0.15
NCX 0.80 ± 0.20 2.22	±	0.41	** 0.45 ± 0.09 1.68	±	0.34	*
SERCA 1.40 ± 0.14 0.85	±	0.08	*** 1.29 ± 0.12 1.00 ± 0.09
PLB 0.92 ± 0.12 1.24 ± 0.42 0.81 ± 0.15 1.02 ± 0.17
PLB/SERCA 0.81 ± 0.16 1.75 ± 0.63 0.77 ± 0.05 0.90 ± 0.14
RYR 0.65 ± 0.07 0.45 ± 0.13 0.45 ± 0.14 0.47 ± 0.09
* p < 0.05 vs P-NF, ** p < 0.01 vs A-NF, *** p < 0.001 vs A-NF.
Conclusions: P-DCM hearts show some of the altered calcium cycling proteins observed 
in A-DCM. Lack of change in SERCA in P-DCM may be important if SERCA gene therapy 
becomes a mainstay of adult therapy. Apparent age-dependent regulation of NCX will be 
explored. This study suggests that P-DCM hearts are not identical to A-DCM hearts, and 
different therapeutic strategies may be appropriate.
10:00 a.m.
1029-30	 Alterations	in	Systemic	Vascular	Properties	in	Young	
Patients	With	Single	Ventricle	Physiology
Shobha Natarajan, Christian Heiss, Michele Mietus-Snyder, Phillip Moore, David F. Teitel, 
Jeff Fineman, Theresa Tacy, University of California, San Francisco, San Francisco, CA
Background: Patients with single ventricle (SV) physiology often develop poor exercise 
capacity and heart failure. The reasons for these complications are poorly understood. 
Adult studies have shown correlations between arterial function and cardiovascular risk. 
Studies in adults with Fontan physiology have demonstrated conduit artery stiffness and 
endothelial dysfunction. We hypothesize that endothelial dysfunction as measured by 
flow-mediated vasodilation (FMD) in the brachial artery and arterial stiffness as measured 
by pulse wave velocity (PWV) are present early in life in patients with SV physiology.
Methods: Patients with SV physiology (n=14) and aged-matched controls (n=17), with a 
median age of 24 months, were studied. Controls were patients with simple heart defects, 
two-ventricle physiology and no left heart or aortic arch obstruction. Endothelial function 
was determined as FMD of the brachial artery using high-resolution ultrasound. FMD was 
calculated as the peak diameter gain following 4.5-minute forearm occlusion. Baseline 
and peak diameters were measured utilizing edge-detection software. PWV between the 
left carotid artery and the left femoral artery was measured using Doppler ultrasound.
Results: FMD was significantly decreased in the study subjects as compared to controls 
(3 ± 4% versus 11 ± 6%, p<0.005). The PWV was not significantly different between 
groups. The systemic vascular resistance was higher in the study versus control group 
(23 ± 4 and 20 ± 6 units, respectively, p<0.05). The hemoglobin was higher in the study 
subjects (13.5 ± 2.0 versus 11.4 ± 1.2 gm/dl in controls, p<0.005) and systemic arterial 
saturation lower (85 ± 6 versus 97 ± 1% in controls, p<0.005).
Conclusions: Endothelial dysfunction is present in young children with SV physiology. In 
contrast, PWV is not increased suggesting that structural alterations and stiffening appear 
later. Endothelial dysfunction may impact ventricular function and exercise capacity in these 
patients. The relationship between endothelial dysfunction, abnormal cardiac development, 
hypoxemia and elevated systemic vascular resistance warrants further investigation.
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1029-31	 Near	Infrared	Spectroscopy	Predicts	Hyperlactatemia	in	
Children	Following	Cardiac	Surgery
Sujata B. Chakravarti, Jason C. Katz, Khanh Nguyen, Alexander Mittnacht, Ingrid 
Hollinger, Umesh Joashi, Barry A. Love, Shubhika Srivastava, Mount Sinai Medical 
Center, New York, NY
Near Infrared Spectroscopy Predicts Hyperlactatemia in Children Following Cardiac Surgery
Background: Blood lactate level is an indicator of global tissue perfusion, but it is 
intermittently monitored and invasive. Near infrared spectroscopy (NIRS) is a non-
invasive tool which has been validated as a measure of regional tissue oxygenation. No 
data exist correlating regional oxyhemoglobin saturation (rSO2) determined by NIRS with 
blood lactate levels.
Methods: Prospective, cross-sectional study of children following cardiac surgery. 
Patients undergoing biventricular repairs were included. Cerebral (C) rSO2, splanchnic 
(S) rSO2, renal rSO2 and skeletal muscle (rectus femoris) rSO2 were recorded every 30 
seconds via NIRS (INVOS 5100, Somanetics Corp.) for 24 hours post-operatively. Blood 
lactate levels measured at 0, 2, 4, 6 and 24 hours post-operatively were correlated with 
rSO2 values which were derived by averaging all values recorded during the preceding 60 minutes.
Results: N= 15. Mean age=1.5 ± 3 years. 35,000 observations were analyzed. 
NIRS Site r p
Cerebral (C) -0.66 <0.0001
Splanchnic (S) -0.58 <0.0001
Renal -0.49 <0.0001
Muscle -0.17 <0.0001
(C+S)/2 -0.70 <0.0001
An averaged cerebral and splanchnic rSO2 < 55% predicted a lactate level of > 3.5 mmol/L 
with a sensitivity and specificity of 89% and 100% respectively, p<0.0001.
Conclusions: Averaged cerebral and splanchnic rSO2 accurately predicts hyperlactatemia 
in children following cardiac surgery. Continuous and non-invasive monitoring using NIRS 
may aid in the earlier recognition and treatment of global hypoperfusion.
10:00 a.m.
1029-32	 Impact	of	Fontan	Type	On	Blood	Flow	Distribution	in	
a	Large	Series	of	Single	Ventricle	Patients	-	A	Cardiac	
Magnetic	Resonance	Velocity	Mapping	Study
Kevin K. Whitehead, Kartik S. Sundareswaran, Resmi A. Krishnankutty, William J. 
Parks, Shiva Sharma, William B. Hyslop, Ajit P. Yoganathan, Mark A. Fogel, Children’s 
Hospital of Philadelphia, Philadelphia, PA, Georgia Institute of Technology, Atlanta, GA
Background: The impact of Fontan type on flow distributions in a large series of Fontan 
pts is unknown. Cardiac magnetic resonance is an ideal tool for evaluating these patients 
because of its non-invasive nature and the accuracy at which it can quantitate blood flow 
with cine phase contrast magnetic resonance imaging.
Methods: We studied 81 Fontan pts (ages 2 - 24 years) with through-plane cardiac 
magnetic resonance velocity mapping to determine flow rates in the inferior (IVC) and 
superior (SVC) vena cavae, and left (LPA) and right (RPA) pulmonary arteries.
Results: Results are summarized in the table. In pts with bilateral SVC’s, the right SVC 
accounted for 49%±15% of caval flow. In 51 pts with aortic flow data, the aortic flow 
was 20% greater than IVC+SVC flow (p<0.01) and 32% greater than LPA+RPA flow 
(p<0.01). Age and body surface area (BSA) correlated with IVC contribution (r = 0.60 and 
0.71 respectively) in a logarithmic pattern. Type of SVC anastomosis or Fontan did not 
significantly affect pulmonary flow splits.
Conclusions:	 Total cardiac output was 2.8 L/min/m2, with equal flows to each lung 
regardless of Fontan type or presence of bilateral SVC. The mean difference in IVC+SVC 
and LPA+RPA flow with aortic flow of 22% and 35% suggests either aortopulmonary 
collaterals, or excluding the azygous, coronary sinus, or upper lobe of RPA flow. IVC 
contribution to total flow increases with BSA and age, consistent with data from healthy 
children. This data should prove a valuable clinical and investigative resource.
10:00 a.m.
1029-33	 The	Impact	of	Right	Heart	Abnormalities	on	Survival	
in	Neonates	with	Hypoplastic	Left	Heart	Syndrome	
Undergoing	Single	Ventricle	Palliation
Haleh C. Heydarian, William L. Border, Christopher Lam, Jim Deddens, Peter B. Manning, 
Pirooz Eghtesady, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Background: Abnormalities of the tricuspid valve (TV) and pulmonary valve (PV) have been 
described in neonates with hypoplastic left heart syndrome (HLHS). We sought to characterize 
the overall extent of right heart involvement, differentiate TV morphological dysplasia from 
functional abnormalities, and evaluate their differential impact on midterm survival.
Methods:	 Hospital records, operative reports, and preoperative echocardiograms of 
consecutive neonates with HLHS undergoing the Norwood operation at a single center 
were retrospectively reviewed. The structure and function of the TV and PV were 
evaluated. Kaplan-Meier survival estimates were calculated. Cox proportional hazards 
regression evaluated the risk of death in the comparison groups.
Results:	Eighty-six neonates were included, with a median follow up of 1 year (1 day 
- 8 yrs). Morphologically dysplastic TV and PV leaflets occurred in 20% and 8% of the 
infants, respectively. Functional TV abnormalities (≥ 1+ TR) occurred in 35%. Any right 
heart abnormality conferred an increased risk of death (hazard ratio = 1.6 [0.8-3.0]). If 
there was ≥ 1+TR (functional abnormality), this conferred an increased mortality risk 
(hazard ratio = 1.4 [0.7-2.8]). However, TV dysplasia alone (morphological abnormality), 
did not increase the risk of death (hazard ratio = 0.71 [0.3-1.7]). When included in a 
multiple Cox proportional hazards model adjusting for traditional risk factors, those 
neonates with any right heart abnormalities had a twofold increased risk of death (hazard 
ratio = 2.1, p=0.041).
Conclusions:	Right-heart abnormalities occur with relative frequency in neonates with 
HLHS and impact midterm survival in these patients. Functional rather than morphological 
abnormalities of the TV leaflets appear to confer the highest risk, which suggests the relative 
importance of geometric changes and ventricular interaction on the subvalvar apparatus.
10:00 a.m.
1029-48	 Ventricular	Wall	Motion	Abnormality	after	Right	
Ventricle	to	Pulmonary	Artery	Shunt	Does	Not	Cause	
Hemodynamic	Impairment	in	Patients	with	Hypoplastic	
Left	Heart	Syndrome
Shinichi Otsuki, Teiji Akagi, Yoshio Okamoto, Kouzou Ishino, Shingo Kasahara, Shunji 
Sano, Okayama University, Okayama, Japan
Background: Recent modification of stage I Norwood procedure using right ventricle 
(RV) to pulmonary artery (PA) shunt provided the stable post operative hemodynamic 
status and excellent surgical results. However, concerns still remain the influence of right 
ventriculotomy and reverse flow from PA to RV upon ventricular function. To investigate of 
the relationship between ventricular wall motion abnormality and its functional outcome.
Methods: Forty-four infants with HLHS underwent modified Norwood procedure using 
an RV-PA shunt. Age at operation ranged from 3 to 57 days (median: 10), and weight 
at operation ranged from 1.6 to 3.9 kg (median: 2.8). Size of shunt used was 4 mm in 6 
patients, 5 mm in 37 patients, and 6 mm in 1 patient. There were 40 hospital survivors 
(91%). Among 40 patients, 33 patients underwent cardiac catheterization before the 
stage II palliation. Using biplane RV angiography (AP and lateral projections), wall motion 
(centerline method) and other hemodynamic variables were evaluated.
Results: Mean age and weight at the time of evaluation was 6.1±2.6 months, 4.9±3.0 
kg, respectively. Although no significant wall motion abnormality was detected by AP 
projection, hypokinesis at the site of ventriculotomy was found in all. Although such wall 
motion abnormality was observed in all, ventricular ejection fraction (60±6%), cardiac index 
(4.76±1.62 l/min/m2) and end-diastolic pressure (5.9±2.5 mmHg) were kept in normal 
range due to compensated hyperkinesis of postero-basal wall. Dyskinesis or aneurysm 
formation at the site of ventriculotomy was not observed. Extension of hypokinetic area 
was not correlated with size of shunt, cardiopulmonary bypass time, or age at operation. 
All 33 patients underwent stage II palliation, bidirectional Glenn anastomosis, at a median 
age of 6.8 months with 2 hospital deaths. Finally, 15 patients underwent Fontan operation 
at the median age of 2.4 years with no early and medium-term mortality.
Conclusions: Although the appearance of ventricular wall motion abnormality could not 
be avoidable in RV-PA shunt for stage I Norwood procedure, such wall motion abnormality 
did not produce significant hemodynamic deterioration in our patient population.
10:00 a.m.
1029-49	 Anatomically	Oriented	Measurement	of	Right	
Ventricular	Volumes	and	Function	by	4D	Semi-
automated	RV	Reconstruction	of	Cardiac	MR	Images
Petra S. Niemann, Thomas Balbach, Christian Galuschky, Michael Blankenhagen, 
Michael Silberbach, Craig Broberg, Michael Jerosch-Herold, David J. Sahn, 
Oregon Health & Science University, Portland, OR, TomTec Imaging Systems, 
Unterschleissheim, Germany
Introduction: Impaired right ventricular (RV) function is common in CHD and CAD. We 
used a multiplanar cine MRI protocol covering inflow, outflow and apical regions of the 
RV, aiming to characterize RV shape and function with a new 4D RV analysis method.
Methods: 30 subjects, 9 CA D, 21 CHD, (40.9 ± 12.11y), were evaluated. ECG-gated images 
were acquired with a 1.5 T magnet. MR gradient echo-gated cine-loops were recorded in 
short, long and rotated long axis views to cover the RV. Processing was performed with 
a program designed to compute RV volumes (TomTec). RV EDV, ESV, SV and EF were 
delineated, and also measured with an offline standard GE MRI analysis package.
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Results: With this new program, there was good myocardial contour detection. The RV 
free wall, tricuspid valve, RVOT and apex could be visualized and reconstructed into a 
dynamic RV model regardless of size/shape. For dedicated 4D RV software: m EF 48% 
± 12%, m EDV 137.6ml ± 84.8ml, m ESV 77.17ml ± 57.27ml, and m SV was 69.6ml ± 
28.3ml. GE MR standard analysis software showed comparable results: m EF 46% ± 
16%; m EDV 148.8ml ± 94.1ml, m ESV 87.1ml ± 89.5ml, and m SV 79.62 ± 32.4 ml 
(r = 0.91). Intraobserver variability for the GE MR analysis was 5.2% EF, 3.7% EDV, 
6.6% ESV, and 6.7% SV, but was lower for the dedicated RV 4D reconstruction analysis 
method: EF, 2.8%; EDV, 3.8%; ESD 4.2%; SV 3.8%.
Conclusions: Precise and reproducible measurements of RV volumes and function were 
obtained with multiplanar cine MR imaging using this new 4D RV analysis method.
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1029-50	 Right	Ventricular	Mechanics	and	QRS	Duration	
after	Repair	of	Tetralogy	of	Fallot	-	Implications	of	
Infundibular	Disease
Anselm Uebing, Derek G. Gibson, Sonya V. Babu-Narayan, Gerhard-Paul Diller, Omer 
Goktekin, Michael Y. Henein, Michael A. Gatzoulis, Wei Li, Royal Brompton Hospital, 
London, United Kingdom
Background:	 Patients after repair of tetralogy of Fallot (ToF) frequently have right 
ventricular (RV) dysfunction and prolonged QRS duration (QRSd) and could thus 
be candidates for cardiac resynchronization therapy (CRT). We aimed to assess the 
relationship between QRSd and the timing of RV wall motion including the RV outflow 
tract (RVOT) in these patients.
Methods:67 ToF patients (aged 34±12 years; 27±8 years after repair) and 35 age-
matched controls were studied by echocardiography and cardiovascular magnetic 
resonance (n=55). Time intervals of the RV cardiac cycle were measured from Doppler 
recordings. Long-axis M-mode recordings were acquired from the RV free wall and the 
RVOT). The delay in onset of long-axis shortening was measured in these segments to 
determine mechanical asynchrony.
Results: Fallot patients showed only minor abnormalities of the RV cardiac cycle unrelated 
to QRSd. RV ejection time was prolonged and correspondingly filling time was reduced 
compared to controls (22.3±2.6 versus 20.0±2.9; p<0.0001, 29.0±3.8 versus 32.7±3.5; 
p<0.0001). Total isovolumic time was normal in ToF patients (8.7±4.0 vs. 7.4±2.9; NS).
There was a consistent delay in RV free wall motion and in RVOT motion in Fallot patients. 
QRSd correlated with the delay in RV free wall motion (r=0.55, p<0.0001) and much more 
so with the delay in RVOT shortening (r=0.82, p<0.0001). Delay in RVOT shortening 
also correlated with RV end systolic volume index (r=0.55, p<0.01), reduced RV ejection 
fraction (r=0.48, p<0.01) and NYHA functional class (r=0.43, p<0.01).
Conclusions: Right ventricular mechanical asynchrony is prevalent in repaired 
Fallot patients and related to QRS duration. Prolonged QRS duration mainly reflects 
abnormalities of the RV infundibulum in these patients.
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1029-52	 Early	Evidence	of	Adverse	Left	Ventricular	Mechanics	
in	Patients	with	Repaired	Tetralogy	of	Fallot
Nikolaos Tzemos, Louise Harris, Shemy Carasso, Harry Rakowski, Samuel Siu, 
Candice Silversides, University Health Network, Toronto, ON, Canada
Background: Left ventricular (LV) dysfunction and the QRS width of the RBBB are 
independent predictors of sudden cardiac death in patients with repaired tetralogy of 
Fallot (TOF). The objective of this study was to explore the relationship between changes 
in QRS duration, LV function and myocardial mechanics in TOF
Methods: Seventy-five patients (mean age 31±2yrs) with repaired TOF (mean age 
at repair 6±1 yrs) and echocardiographically preserved LV function, were categorized 
according to QRS duration. LV and RV function and volumes were assessed by cardiac 
MRI. LV regional function and dyssynchronous contraction were assessed by speckle-2D 
ultrasound using longitudinal strain (ε) and post-systolic shortening respectively (PSS: 
peak of longitudinal strain occurring after aortic valve closure).
Results: At QRS duration <140msec, no abnormalities of LV myocardial mechanics were 
observed. A stepwise reduction in longitudinal mean strain and PSS was observed with 
progressive increases in QRS width (table) such that all patients with QRS >180msec 
had PSS. Corresponding decreases in LV EF and increases in volumes occurred with 
progressive QRS widening (Table). Septal wall strain was correlated with QRS duration 
(r=0.9, p<0.001).
Conclusions: In patients with TOF, RV conduction abnormalities are associated with 
changes in LV mechanics that precede significant clinical impairment in LV systolic 
function. These changes are also associated with progressive increases in QRS width.
Legend: ¶ P<0.05 between groups when indicated
Variable <140ms (n=21) 140-159 ms(n=17) 160-179ms (n=16) >180ms (n=21)
LVEDV (cc/m2) 116±10 126±5 139±10 191±15¶
RVEDV (cc/m2) 217±12 243±20 268±15 301±20
LVEF% 58±1 55±2 52±4 45±3¶
RVEF% 46±1 44±3 38±5 34±4¶
ε lateral wall -23±1 -22±1 -19±1 -18±1¶
ε septal wall -20±1 -18±2 -12±2 -10±2¶
PSS (n) 0 2 10 23
